Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3016038	u-k	mmol/l (mmol/l)	2551	3454	0.38%
3016038	u-k	— (—)	415	457	100.00%	Distribution not available
3016038	u-k	mmol/l____ (mmol/l)	39	41	0.00%
3016038	u-k	mmol/L (mmol/l)	24	29	0.00%
3016038	u-k	MMOL/L (mmol/l)	17	18	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Metabolic disorders

1129

939

7.33

307.65

1.5

1.3

32.83

37.13

mmol/l

4.60

995

823

Hypo-osmolality and hyponatraemia

1334

288

54.04

307.65

1.2

1.1

31.38

37.10

mmol/l

3.82

1168

235

Hypokalaemia

330

171

20.40

307.65

1.7

1.3

32.90

36.21

mmol/l

0.91

298

137

Other disorders of fluid, electrolyte and acid-base balance

1588

505

32.58

307.65

1.4

1.2

31.85

37.09

mmol/l

5.04

1399

423

Malaise and fatigue

623

960

5.19

273.41

1.4

1.3

32.01

35.87

mmol/l

3.10

537

850

Implicit Sepsis

753

1625

3.45

192.78

1.5

1.2

33.15

34.64

mmol/l

0.88

658

1414

Endocrine, nutritional and metabolic diseases

515

488

5.37

192.76

1.4

1.3

33.77

38.77

mmol/l

3.12

463

441

Anaemias

207

17.24

186.22

1.8

1.9

32.28

35.15

mmol/l

0.42

188

Substance abuse, excluding more controls

505

982

4.34

184.95

1.2

30.02

36.22

mmol/l

6.44

436

867

Implicit Sepsis, including avohilmo

769

1678

3.31

182.83

1.4

1.2

33.51

34.51

mmol/l

0.51

674

1464

Convulsions, not elsewhere classified

285

454

6.31

167.38

1.3

1.5

29.06

36.68

mmol/l

5.55

237

406

Condition for Implicit Sepsis (Organ dysfunction codes)

759

1678

3.16

166.73

1.5

1.2

33.74

34.59

mmol/l

0.41

668

1466

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

850

1951

2.96

166.07

1.4

1.3

31.80

34.97

mmol/l

3.34

746

1717

Renal tubulo-interstitial diseases

769

1922

2.96

153.64

1.3

31.47

34.99

mmol/l

3.88

679

1682

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

743

1654

3.06

153.37

1.5

1.2

33.74

34.52

mmol/l

0.37

661

1445

All kidney diseases

804

1934

2.81

142.84

1.4

1.3

31.68

35.02

mmol/l

3.70

718

1698

Exclusions for E4_PCOS_BROAD

267

482

5.68

140.53

1.6

1.4

33.70

36.47

mmol/l

0.88

243

435

Alcohol use disorder, Swedish definition

491

1268

3.56

140.32

1.3

1.2

31.07

35.89

mmol/l

4.34

424

1124

General symptoms and signs

736

1202

3.09

139.78

1.3

33.45

35.46

mmol/l

1.22

638

1077

Substance abuse

505

1369

3.46

139.37

1.2

30.02

35.77

mmol/l

6.15

436

1211

Mental and behavioural disorders due to psychoactive substance use

516

1400

3.41

138.57

1.2

29.86

35.81

mmol/l

6.71

445

1235

507

1333

3.43

136.54

1.3

1.2

30.91

35.96

mmol/l

4.88

436

1179

Other bacterial diseases

790

1909

2.76

135.92

1.5

1.2

32.89

34.30

mmol/l

0.88

691

1678

517

1352

3.36

133.76

1.3

1.2

31.15

35.87

mmol/l

4.38

445

1197

Implicit bacterial Sepsis, including avohilmo

488

1175

3.50

132.42

1.5

1.1

33.38

34.92

mmol/l

0.67

425

1007

Mental and behavioural disorders due to alcohol, excluding acute intoxication

413

1104

3.75

130.77

1.2

30.66

36.06

mmol/l

4.48

356

977

Bacterial Sepsis

490

1196

3.43

128.77

1.5

1.2

33.43

34.99

mmol/l

0.68

428

1026

Mental and behavioural disorders due to alcohol

444

1215

3.52

126.44

1.2

30.66

36.29

mmol/l

5.16

382

1078

Disorders of other endocrine glands

461

1358

3.38

124.41

1.6

1.4

32.95

34.88

mmol/l

0.93

422

1176

Other bacterial diseases, including avohilmo

791

1876

2.65

123.93

1.5

1.3

33.06

34.24

mmol/l

0.68

700

1652

Pneumonia, organism unspecified

733

1866

2.71

123.35

1.4

1.3

31.07

34.96

mmol/l

4.57

642

1648

Benzodiazepine use

782

2037

2.61

121.53

1.2

29.90

35.39

mmol/l

9.32

657

1808

Implicit bacterial Sepsis

447

1115

3.48

121.51

1.5

1.1

33.47

34.76

mmol/l

0.49

387

956

Bacterial infection, other or unspecified, including avohilmo

557

1511

3.05

121.19

1.5

1.2

32.90

34.51

mmol/l

0.88

487

1312

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

775

1999

2.60

119.14

1.4

1.3

31.24

34.95

mmol/l

4.47

682

1771

Hyperkalaemia

105

15.36

119.11

1.3

1.1

33.03

39.88

mmol/l

1.28

Influenza and pneumonia

799

1920

2.58

118.88

1.5

1.3

31.74

34.77

mmol/l

3.14

706

1697

Alcohol use disorder, ICD-based

376

1028

3.70

117.09

1.2

30.42

35.93

mmol/l

4.51

324

908

Pneumonias (Asthma/COPD co-morbidities)

775

1984

2.57

115.74

1.4

1.3

31.48

34.85

mmol/l

3.76

684

1756

Explicit Sepsis, including avohilmo

442

1217

3.33

114.03

1.7

1.2

31.93

34.82

mmol/l

1.89

397

1054

All pneumoniae

772

1985

2.54

112.93

1.5

1.3

31.36

34.84

mmol/l

3.98

680

1758

Explicit Sepsis

435

1200

3.34

112.89

1.7

1.2

31.88

35.00

mmol/l

2.12

390

1038

Heart failure, not strict

629

1518

2.81

112.20

1.2

32.85

35.13

mmol/l

1.49

555

1329

Hypertensive diseases (excluding secondary)

328

425

4.52

110.29

1.3

1.4

33.17

33.74

mmol/l

0.14

302

378

Other and unspecified anaemias

460

1391

3.15

108.85

1.3

1.2

32.22

35.00

mmol/l

1.71

401

1194

Aplastic and other anaemias

485

1470

3.06

108.71

1.3

1.2

32.32

34.87

mmol/l

1.56

425

1265

Other anaemias

463

1403

3.13

108.55

1.3

1.2

32.29

34.92

mmol/l

1.57

403

1204

Syncope and collapse

377

880

3.61

107.81

1.4

1.2

35.11

35.77

mmol/l

0.19

328

773

Bacterial infection, other or unspecified

511

1462

2.98

107.59

1.5

1.2

33.25

34.49

mmol/l

0.57

443

1271

Mood disorders, excluding more controls

660

1443

2.70

105.77

1.3

1.2

31.42

35.14

mmol/l

3.50

564

1277

Fever of other and unknown origin

410

1073

3.34

105.22

1.7

1.3

33.22

35.77

mmol/l

1.27

370

956

Heart failure and antihypertensive medication

210

220

6.28

102.89

1.2

1.3

33.38

35.90

mmol/l

0.57

187

196

Volume depletion

123

134

9.40

102.41

2.3

1.2

34.72

37.43

mmol/l

0.48

113

108

Cerebrovascular diseases (FINNGEN)

231

303

5.40

101.61

1.2

1.3

33.96

35.80

mmol/l

0.40

202

265

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

669

1503

2.62

100.67

1.4

1.2

31.15

34.74

mmol/l

3.68

587

1332

669

1503

2.62

100.67

1.4

1.2

31.15

34.74

mmol/l

3.68

587

1332

Pure hypercholesterolaemia

422

801

3.37

99.96

1.2

1.1

34.19

37.31

mmol/l

1.65

362

690

Nausea and vomiting

309

816

3.75

97.12

1.9

1.3

34.51

35.84

mmol/l

0.42

272

710

Hypertension, essential

481

880

3.11

96.82

1.2

33.16

34.93

mmol/l

0.82

428

776

Septicaemia

424

1269

3.08

96.48

1.7

1.2

31.83

34.69

mmol/l

1.84

378

1111

Disorders of lipoprotein metabolism and other lipidaemias

437

831

3.21

95.18

1.2

1.1

34.31

37.27

mmol/l

1.53

371

719

Injuries to the head

808

2085

2.31

94.36

1.3

33.31

34.09

mmol/l

0.39

701

1844

Anxiety disorders, excluding more controls

570

1354

2.71

93.89

1.3

1.2

32.06

34.97

mmol/l

1.99

505

1197

Hypertensive diseases

487

926

2.98

91.71

1.2

1.3

33.01

34.83

mmol/l

0.85

437

822

Hypertension

486

924

2.98

91.50

1.2

1.3

33.04

34.87

mmol/l

0.86

436

820

Other septicaemia

386

1176

3.13

91.09

1.7

1.2

32.11

34.35

mmol/l

1.18

343

1027

Other septicaemia, including avohilmo

392

1199

3.11

91.05

1.7

1.2

32.16

34.49

mmol/l

1.25

349

1047

Any mental disorder

724

1490

2.45

90.86

1.3

32.60

35.11

mmol/l

1.93

634

1321

Headache

429

1106

3.02

90.61

1.4

1.3

32.01

35.27

mmol/l

2.00

375

987

Intracranial trauma

422

932

3.08

88.73

1.3

1.4

32.55

35.52

mmol/l

1.51

363

837

Cardiovascular diseases (excluding rheumatic etc)

347

550

3.63

88.34

1.5

1.9

35.05

34.36

mmol/l

0.17

322

495

Acute tubulo-interstitial nephritis

512

1632

2.67

88.30

1.3

1.2

31.89

35.03

mmol/l

2.43

443

1420

Persons encountering health services for specific procedures and health care

747

1909

2.32

88.03

1.6

1.3

33.82

34.04

mmol/l

0.09

670

1666

Other antidepressants

690

1457

2.43

85.99

1.3

32.98

35.59

mmol/l

1.98

584

1313

Other heart diseases

280

455

4.03

85.83

1.5

1.6

35.51

34.87

mmol/l

0.13

259

408

Diseases of arteries, arterioles and capillaries (FINNGEN)

188

234

5.61

85.32

1.2

32.05

34.56

mmol/l

0.56

165

203

Disorders of mineral metabolism

100

106

9.66

85.01

2.3

1.3

34.41

37.61

mmol/l

0.51

Alcohol dependence

248

645

3.90

83.27

1.2

1.1

30.04

37.41

mmol/l

5.08

213

570

Renal failure

459

1457

2.71

81.64

1.3

1.2

30.21

35.56

mmol/l

6.01

415

1247

Bleeding

644

1946

2.34

80.45

1.4

1.2

33.08

34.36

mmol/l

0.67

557

1703

Epilepsy

301

915

3.32

79.36

1.3

1.5

31.56

35.09

mmol/l

1.95

260

796

Other CVD (FINNGEN)

122

118

8.03

79.20

1.1

32.32

36.98

mmol/l

0.87

102

Tramadol

536

1258

2.58

79.10

1.3

1.1

31.96

34.33

mmol/l

1.38

460

1118

Secondary hypertension

10.29

78.71

1.3

29.26

37.84

mmol/l

2.10

Anxiety (asthma-related co-morbidities)

401

1059

2.90

78.71

1.4

30.82

35.33

mmol/l

3.12

358

946

Hypothyroidism (congenital or acquired)

124

9.98

78.55

2.3

1.5

32.82

36.25

mmol/l

0.47

115

All chronic kidney diseases

460

1384

2.67

78.49

1.3

1.2

30.31

35.37

mmol/l

5.29

415

1199

Constipation

660

1989

2.26

76.02

1.3

31.84

34.69

mmol/l

2.40

561

1758

Depression or dysthymia

437

841

2.86

75.65

1.3

1.2

32.50

36.57

mmol/l

2.76

370

761

Hypothyroidism and >3 levothyroxin purchases

120

9.67

74.68

1.8

1.5

32.35

36.25

mmol/l

0.56

111

Hypothyroidism, levothyroxine purchases

120

9.67

74.68

1.8

1.5

32.35

36.25

mmol/l

0.56

111

Any death

525

1500

2.47

73.88

1.2

34.74

34.35

mmol/l

0.14

462

1304

Cardiovascular diseases

310

469

3.53

73.80

1.6

2.0

35.20

35.23

mmol/l

0.01

289

424

Depression medications

132

9.02

73.61

1.5

1.4

36.98

35.04

mmol/l

0.23

122

Osteopathies and chondropathies

469

1721

2.51

72.87

1.3

1.2

31.63

34.36

mmol/l

1.80

387

1507

Osteoporosis

314

941

3.12

72.77

1.3

1.2

31.56

34.41

mmol/l

1.37

251

810

Acute renal failure

249

715

3.54

72.46

1.3

1.2

30.10

35.24

mmol/l

3.25

231

598

Symptoms and signs involving cognition, perception, emotional state and behaviour

658

1991

2.22

72.38

1.3

1.2

33.20

34.44

mmol/l

0.66

574

1756

Oxycodone

340

988

2.97

71.80

1.3

1.1

34.55

34.70

mmol/l

0.04

294

867

Oedema, not elsewhere classified

260

751

3.41

71.59

1.2

32.49

35.34

mmol/l

1.15

227

651

Concussion

350

926

2.95

71.38

1.3

1.4

32.43

35.65

mmol/l

1.62

303

831

Other disorders of adrenal gland

117

8.40

70.83

1.4

1.2

29.98

36.12

mmol/l

1.33

107

Intracranial injury

449

1683

2.50

69.74

1.3

33.96

34.57

mmol/l

0.20

385

1486

Psychiatric diseases

604

1296

2.35

69.61

1.3

32.91

35.69

mmol/l

1.96

532

1153

Complications of surgical and medical care, not elsewhere classified

685

2144

2.14

69.10

1.4

1.2

32.79

34.30

mmol/l

0.91

597

1880

Mood [affective] disorders

691

2076

2.14

69.04

1.3

31.20

34.69

mmol/l

3.47

592

1837

Antihypertensive medication - note that there are other indications

302

465

3.41

68.24

1.3

2.0

33.36

36.05

mmol/l

0.91

278

430

Use of hypnotics and sedatives

693

1847

2.15

68.21

1.2

31.86

35.06

mmol/l

2.87

596

1639

Mood disorders

690

2080

2.13

68.04

1.3

31.24

34.66

mmol/l

3.36

591

1840

Implicit viral Sepsis, including avohilmo

280

903

3.13

67.15

1.8

1.2

32.82

34.66

mmol/l

0.65

255

783

Depression

640

1982

2.17

66.71

1.3

31.66

34.52

mmol/l

2.30

549

1753

Any gastric operation

440

831

2.67

65.75

1.5

1.3

34.37

35.67

mmol/l

0.48

396

727

GASTRO-related operations

440

831

2.67

65.75

1.5

1.3

34.37

35.67

mmol/l

0.48

396

727

Symptoms and signs concerning food and fluid intake

122

216

5.75

65.57

1.4

1.5

26.15

36.48

mmol/l

4.89

108

191

Dental caries

225

606

3.54

64.94

1.6

1.2

30.15

35.33

mmol/l

2.64

201

544

Nutritional anaemias

423

1643

2.48

64.37

1.4

1.2

32.39

34.85

mmol/l

1.34

368

1418

Symptoms and signs involving the urinary system

564

1922

2.23

64.36

1.3

1.2

33.47

34.36

mmol/l

0.39

480

1687

Focal epilepsy

218

620

3.57

64.35

1.3

1.4

33.64

35.68

mmol/l

0.64

189

549

All anxiety disorders

403

1220

2.58

63.98

1.4

1.3

30.78

34.54

mmol/l

2.40

360

1076

Viral Sepsis

210

587

3.63

63.66

2.0

1.2

31.71

35.31

mmol/l

1.35

194

503

Diarrhoea and gastroenteritis of presumed infectious origin

501

1963

2.29

63.51

1.7

1.3

31.71

35.03

mmol/l

2.52

452

1711

Implicit viral Sepsis

209

587

3.61

62.91

2.0

1.2

31.65

35.31

mmol/l

1.37

193

503

COPD (mode)

259

623

3.28

62.85

1.2

1.1

31.82

35.94

mmol/l

2.03

225

545

Asthma, unspecified (mode), excluding more controls

336

852

2.84

62.74

1.2

30.91

35.74

mmol/l

3.63

284

756

Open wound of head

421

1625

2.45

62.65

1.3

33.97

34.29

mmol/l

0.09

358

1434

Neurotic, stress-related and somatoform disorders

588

1869

2.18

62.37

1.4

1.3

32.09

33.80

mmol/l

0.94

521

1639

Anxiety disorders

593

1889

2.16

61.88

1.4

1.3

32.06

33.73

mmol/l

0.92

526

1656

Adrenocortical insufficiency

8.66

61.66

1.3

1.2

30.75

34.35

mmol/l

0.56

Intestinal infectious diseases

640

2297

2.08

61.57

1.6

1.3

31.92

34.57

mmol/l

2.10

576

2002

STROKE

386

995

2.63

61.35

1.2

33.36

33.96

mmol/l

0.18

341

867

Fall on same level

700

1817

2.06

60.65

1.3

1.4

32.43

34.52

mmol/l

1.51

606

1630

Heart failure,strict

416

1172

2.50

60.10

1.2

33.34

35.22

mmol/l

0.84

371

1012

First line medication for Crohn's disease

694

1825

2.05

59.69

1.4

1.3

32.27

34.67

mmol/l

1.86

613

1607

Infections, IBD-co-morbidities

122

145

5.98

59.56

1.7

1.2

29.06

39.38

mmol/l

3.45

110

131

Retention of urine

292

813

2.93

59.55

1.2

31.81

35.61

mmol/l

2.17

251

714

Diseases of liver

293

1041

2.84

59.45

1.3

1.2

31.81

34.81

mmol/l

1.50

263

905

Focal epilepsy, strict definition

204

586

3.53

59.38

1.4

34.17

35.50

mmol/l

0.35

177

521

Other symptoms and signs involving cognitive functions and awareness

381

1355

2.51

59.06

1.4

1.2

33.28

35.00

mmol/l

0.79

328

1172

Early onset COPD, excluding more controls

163

402

4.10

58.93

1.2

1.1

31.46

36.49

mmol/l

1.72

141

356

Schizophrenia or delusion, excluding more controls

205

584

3.50

58.92

1.2

27.29

35.91

mmol/l

6.58

177

508

Diseases of oesophagus, stomach and duodenum

676

1964

2.04

58.56

1.3

1.2

31.83

34.77

mmol/l

2.66

593

1719

Non-invasive ventilation

159

328

4.22

57.29

1.2

1.3

32.41

37.83

mmol/l

1.79

142

291

Caries of dentine

197

550

3.49

56.05

1.5

1.2

29.80

35.25

mmol/l

2.61

175

490

Asthma, unspecified (mode)

350

973

2.61

56.04

1.2

31.09

35.54

mmol/l

3.38

296

865

Complications of procedures, not elsewhere classified

549

2103

2.11

55.98

1.4

1.2

32.95

34.40

mmol/l

0.77

483

1840

Persons encountering health services in other circumstances

300

1103

2.71

55.67

1.3

1.2

30.98

34.50

mmol/l

1.99

260

948

Complications of medical and surgical care

518

2193

2.13

55.33

1.5

1.2

33.93

33.76

mmol/l

0.06

457

1905

Any reimbursement code in KELA

268

427

3.16

53.40

1.4

1.2

36.84

34.28

mmol/l

0.77

242

381

Hyperfunction of pituitary gland

7.87

53.28

2.0

1.2

35.95

34.63

mmol/l

0.14

Atrial fibrillation and flutter

174

283

4.00

52.90

1.2

33.22

35.08

mmol/l

0.43

154

246

Paralytic ileus and intestinal obstruction

233

778

3.03

52.90

2.2

1.2

33.44

35.07

mmol/l

0.46

210

672

Other functional intestinal disorders

359

1348

2.44

52.54

1.8

1.3

33.05

35.04

mmol/l

0.83

316

1188

Opioids

547

1325

2.14

51.77

1.3

1.1

34.90

34.13

mmol/l

0.30

469

1182

Cerebrovascular diseases

532

1777

2.09

50.91

1.2

33.85

34.39

mmol/l

0.20

464

1547

Diseases of the digestive system

365

1543

2.37

50.91

2.1

1.2

33.22

34.73

mmol/l

0.62

321

1331

Iron deficiency anaemia

355

1467

2.39

50.66

1.4

1.2

32.32

34.57

mmol/l

1.10

310

1261

Other anxiety disorders

286

910

2.69

50.66

1.4

28.91

34.15

mmol/l

3.53

259

800

Other disorders of urethra and urinary system

452

1424

2.22

50.50

1.3

1.2

31.86

34.82

mmol/l

2.00

398

1249

COPD

356

1205

2.42

50.01

1.2

32.28

35.19

mmol/l

1.60

305

1046

Focal epilepsy, mode (most common among epilepsy diagnosis)

183

548

3.39

50.00

1.4

33.84

35.95

mmol/l

0.59

159

488

Persons encountering health services in other circumstances, wide

706

1897

1.92

49.98

1.4

1.2

33.11

34.63

mmol/l

0.91

627

1650

Dyspnoea

590

2159

1.98

49.49

1.2

32.54

34.39

mmol/l

1.12

502

1902

Other heart diseases, wide

528

1534

2.09

49.24

1.4

35.12

33.79

mmol/l

0.58

470

1350

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

156

419

3.70

49.04

1.5

1.2

27.53

36.01

mmol/l

4.60

139

371

Dizziness and giddiness

486

1806

2.10

48.69

1.2

34.06

34.33

mmol/l

0.09

419

1578

ILD medications: immunosuppressive drugs

422

1753

2.19

48.41

1.4

1.3

32.14

34.74

mmol/l

1.45

372

1560

Certain infectious and parasitic diseases

550

1330

2.08

48.06

1.3

33.38

34.85

mmol/l

0.72

483

1164

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

610

1980

1.95

47.85

1.7

1.3

33.71

34.46

mmol/l

0.32

535

1752

Delirium, not induced by alcohol and other psychoactive substances

149

401

3.78

47.81

1.1

31.97

35.33

mmol/l

0.94

124

331

Other chronic obstructive pulmonary disease

340

1166

2.41

47.32

1.2

32.33

35.08

mmol/l

1.41

291

1012

Pain, not elsewhere classified

189

599

3.18

47.00

1.5

1.3

35.13

35.67

mmol/l

0.10

161

528

Alcoholic liver disease

112

249

4.59

46.66

1.2

29.23

35.69

mmol/l

2.39

219

Autoimmune diseases excluding thyroid diseases

617

1719

1.95

46.53

1.5

1.3

32.57

34.77

mmol/l

1.43

552

1524

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

197

374

3.34

46.38

1.2

1.3

34.62

34.88

mmol/l

0.05

179

327

Care involving use of rehabilitation procedures

423

1780

2.15

46.11

1.5

1.3

33.71

34.38

mmol/l

0.24

384

1544

Cardiac arrhythmias

308

775

2.56

46.09

1.3

34.65

34.12

mmol/l

0.14

276

689

Heart failure, strict

446

1462

2.14

45.22

1.2

33.02

35.16

mmol/l

1.14

397

1254

Parasetamol

377

805

2.38

45.18

1.2

1.4

34.53

35.86

mmol/l

0.45

326

727

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

420

1954

2.12

44.93

1.5

1.2

33.70

34.24

mmol/l

0.19

373

1685

Alcohol abuse, main dg, excluding more controls

116

273

4.30

44.83

1.2

26.97

37.92

mmol/l

5.93

248

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

149

423

3.58

44.37

1.2

33.08

34.48

mmol/l

0.29

126

368

Other chronic obstructive pulmonary disease, including avohilmo

395

1491

2.19

44.33

1.2

31.80

34.94

mmol/l

2.04

337

1285

Codeine

499

1306

2.07

44.24

1.3

1.1

33.86

34.04

mmol/l

0.06

419

1163

Atrial fibrillation and flutter with reimbursement

146

233

3.98

43.84

1.2

33.06

35.45

mmol/l

0.52

132

200

Transplanted organ and tissue status

110

254

4.42

43.70

1.7

1.3

27.88

37.19

mmol/l

3.74

104

226

Hyperlipidaemia, other/unspecified

195

583

3.02

43.49

1.1

32.99

37.53

mmol/l

1.83

169

496

Selective serotonin reuptake inhibitors

561

1480

1.98

43.44

1.3

32.16

35.62

mmol/l

2.75

468

1336

Used for control exclusion in common control thyroid runs

593

1543

1.94

43.44

1.6

1.2

33.33

35.07

mmol/l

0.97

534

1369

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

396

1867

2.13

42.99

1.4

1.2

33.73

34.38

mmol/l

0.22

350

1612

General examination and investigation of persons without complaint and reported diagnosis

375

844

2.32

42.91

1.3

1.2

33.49

34.82

mmol/l

0.45

330

746

Other diseases of intestines

609

1795

1.90

42.58

1.7

1.3

33.70

34.51

mmol/l

0.34

535

1590

All-cause Heart Failure

434

1447

2.10

42.28

1.2

32.90

35.11

mmol/l

1.16

385

1241

Injuries to the abdomen, lower back, lumbar spine and pelvis

318

1366

2.31

42.14

1.3

1.2

32.87

34.58

mmol/l

0.69

270

1181

Autoimmune diseases excluding thyroid diseases, strict definition

582

1653

1.92

42.07

1.5

1.2

32.95

34.80

mmol/l

1.03

517

1465

Medical observation and evaluation for suspected diseases and conditions

378

847

2.29

41.98

1.4

1.2

34.07

34.83

mmol/l

0.23

320

749

Hypopituitarism

183

5.03

41.79

2.2

1.4

32.79

37.75

mmol/l

1.05

172

COPD, early/later onset

344

1288

2.26

41.78

1.2

32.29

35.35

mmol/l

1.72

294

1106

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

464

2030

2.00

41.55

1.2

32.33

34.34

mmol/l

1.18

415

1751

Intestinal stricture

262

1057

2.50

41.47

2.5

1.2

35.30

34.43

mmol/l

0.21

237

900

Fracture of lumbar spine and pelvis

220

814

2.73

41.36

1.3

1.1

33.27

34.73

mmol/l

0.44

182

691

COPD/asthma/ILD related infections

575

1503

1.92

40.77

1.3

1.2

33.41

34.74

mmol/l

0.67

501

1332

COPD/asthma related infections

575

1503

1.92

40.77

1.3

1.2

33.41

34.74

mmol/l

0.67

501

1332

ILD medications: prednisolone, methylprednisolone, prednisone

635

1921

1.84

40.75

1.3

1.2

32.11

34.67

mmol/l

1.93

545

1699

Implicit fungal Sepsis, including avohilmo

172

5.11

40.73

1.4

1.1

30.65

36.48

mmol/l

1.47

147

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

161

218

3.72

40.62

1.2

1.7

37.48

36.45

mmol/l

0.17

152

199

ILD medications

658

1951

1.82

40.50

1.4

1.3

32.16

34.74

mmol/l

2.01

570

1728

COPD, hospital admissions

338

1279

2.24

40.44

1.2

32.51

35.33

mmol/l

1.49

290

1096

Covid-19 confirmed case

289

1233

2.36

40.27

1.2

33.05

34.64

mmol/l

0.58

260

1060

Pain in throat and chest

478

1412

2.01

40.16

1.2

1.4

34.18

34.45

mmol/l

0.08

411

1262

Other reaction to severe stress, and adjustment disorders

211

780

2.72

39.75

1.5

1.2

33.90

34.54

mmol/l

0.13

188

688

Alcohol withdrawal state with delirium

150

5.39

39.68

1.2

29.77

36.14

mmol/l

1.48

140

Hypertensive heart and/or renal disease

177

416

3.13

39.56

1.1

32.40

35.90

mmol/l

1.15

157

360

COPD related to multimorbidity

306

1127

2.31

39.39

1.2

1.1

31.92

35.35

mmol/l

2.00

262

967

Substance use, excluding alcohol

143

428

3.37

39.18

1.4

1.2

27.15

36.62

mmol/l

5.59

122

384

Osteoporosis with pathological fracture (FG)

104

251

4.25

39.16

1.3

1.1

30.36

32.93

mmol/l

0.56

208

Autoimmune diseases

625

1733

1.84

38.77

1.5

1.3

33.10

34.78

mmol/l

0.97

556

1536

Abnormalities of breathing

494

1442

1.97

38.69

1.3

1.4

33.88

34.32

mmol/l

0.15

427

1292

Other and unspecified iron deficiency

270

1140

2.38

38.50

1.3

1.2

31.79

34.56

mmol/l

1.24

233

977

Haemorrhage from respiratory passages

259

941

2.45

38.48

1.5

1.2

36.78

35.52

mmol/l

0.33

227

828

Exposure to unspecified factor

619

2354

1.79

38.16

1.4

1.3

32.38

34.26

mmol/l

1.18

528

2084

Other or unspecified ileus, impaction or obstruction

163

538

3.06

38.00

2.5

1.1

34.31

35.24

mmol/l

0.18

149

459

Chronic kidney disease

267

1085

2.39

37.96

1.4

1.2

30.21

35.95

mmol/l

4.46

242

922

Inflammatory bowel disease treatment related agents

660

2066

1.78

37.71

1.3

32.43

34.44

mmol/l

1.34

566

1828

Other neurological diseases

483

1967

1.91

37.35

1.4

1.2

34.19

34.08

mmol/l

0.04

425

1700

Asthma, excluding more controls

372

878

2.18

37.12

1.3

1.2

31.29

35.43

mmol/l

2.61

316

780

L04AD Calcineurin inhibitors

111

292

3.87

37.05

1.7

1.4

27.56

36.31

mmol/l

3.45

104

269

Provisional assignment of new diseases of uncertain etiology

353

1678

2.10

36.97

1.3

1.2

33.48

34.37

mmol/l

0.31

318

1453

Stroke, including SAH

435

1580

1.99

36.90

1.2

34.04

34.45

mmol/l

0.13

377

1369

Codes for special purposes

353

1680

2.09

36.84

1.3

1.2

33.48

34.35

mmol/l

0.30

318

1454

Erysipelas, including avohilmo

440

1662

1.97

36.76

1.2

1.1

33.85

34.20

mmol/l

0.11

379

1451

Other medical care

344

1358

2.14

36.70

1.3

1.2

35.53

34.76

mmol/l

0.26

305

1158

Type 1 diabetes

180

640

2.83

36.59

1.7

1.3

30.28

35.83

mmol/l

3.00

164

570

Unspecified mental disorder

249

1042

2.40

36.36

1.2

28.39

35.47

mmol/l

6.17

214

906

Falls/tendency to fall

562

1517

1.86

36.30

1.3

1.4

31.92

34.89

mmol/l

2.37

493

1364

Intestinal infectious diseases, including avohilmo, including avohilmo

673

2163

1.74

35.71

1.3

1.2

32.58

34.55

mmol/l

1.31

601

1884

Hypertensive Heart Disease

160

395

3.10

35.55

1.2

1.1

32.87

35.95

mmol/l

0.87

141

341

Insulin, fast-acting

260

1121

2.34

35.50

1.6

1.2

30.49

35.48

mmol/l

3.52

233

976

Other diseases of urinary system

547

1669

1.85

35.44

1.4

1.3

32.51

34.77

mmol/l

1.40

475

1470

Acute alcohol intoxication

175

626

2.82

35.30

1.2

26.70

37.22

mmol/l

8.80

147

559

Other pulmonary diagnosis

412

1009

2.05

35.08

1.2

33.52

35.34

mmol/l

0.78

359

899

Unspecified fall

360

1742

2.04

34.95

1.3

1.4

32.46

35.00

mmol/l

1.15

303

1519

Persons encountering health services for other counselling and medical advice, not elsewhere classified

626

1887

1.77

34.84

1.4

1.2

33.47

34.53

mmol/l

0.52

560

1644

Oral corticosteroids

604

2004

1.77

34.70

1.3

1.2

32.70

34.31

mmol/l

0.93

514

1766

Kela-code for severe mental illness

229

944

2.44

34.64

1.2

27.73

35.35

mmol/l

6.56

195

822

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

600

2190

1.76

34.50

1.6

1.2

32.50

34.50

mmol/l

1.24

539

1907

Type 1 diabetes, wide definition, subgroup 1

150

501

3.02

34.22

1.8

1.3

30.32

35.78

mmol/l

2.46

136

452

Symptoms and signs involving the digestive system and abdomen

560

1541

1.83

34.18

1.2

1.3

33.41

35.05

mmol/l

0.86

492

1357

Schizophrenia or delusion

205

810

2.55

33.97

1.2

27.29

34.81

mmol/l

5.70

177

713

Excluding asthma or asthma-COPD overlap

408

1009

2.03

33.89

1.2

33.26

35.34

mmol/l

0.99

356

899

COPD, hospital admission 2, with asthma infections

246

903

2.36

33.53

1.2

1.1

32.25

35.34

mmol/l

1.45

210

767

Insulin, fast-acting or short human

261

1156

2.27

33.50

1.6

1.2

30.48

35.46

mmol/l

3.57

234

997

Asthma (only as main-diagnosis), excluding more controls

340

878

2.15

33.42

1.3

1.2

31.36

35.43

mmol/l

2.44

288

780

Dialysis, with operation codes

119

352

3.43

33.39

1.5

1.2

31.05

35.89

mmol/l

1.22

113

308

Recurrent or chronic depression

204

539

2.64

33.33

1.4

1.2

33.96

36.06

mmol/l

0.53

170

490

Schizophrenia, schizotypal and delusional disorders

205

819

2.52

33.21

1.2

27.29

34.85

mmol/l

5.78

177

719

Fungal Sepsis

6.02

32.71

2.1

1.1

32.67

37.26

mmol/l

0.70

Hernia of abdominal wall, postoperative

120

359

3.35

32.54

2.0

1.2

33.29

34.94

mmol/l

0.28

110

305

COPD differential diagnosis

404

1013

2.01

32.38

1.2

33.36

35.28

mmol/l

0.87

352

899

ILD differential diagnosis

404

1013

2.01

32.37

1.2

33.36

35.28

mmol/l

0.87

352

899

COPD, hospital admissions 3, with asthma pneumonia sepsis

213

741

2.49

32.33

1.2

1.1

32.47

35.63

mmol/l

1.30

182

634

Personality disorders, excluding more controls

124

382

3.26

32.32

1.4

1.2

27.97

36.39

mmol/l

3.97

104

343

Cystitis

471

1503

1.87

32.29

1.5

1.3

32.00

34.78

mmol/l

1.88

402

1323

Asthma

391

1001

2.02

32.28

1.3

1.2

31.47

35.32

mmol/l

2.51

332

891

Postmenopausal osteoporosis with pathological fracture

235

4.02

32.19

1.2

1.1

29.63

32.67

mmol/l

0.69

199

Other disorders of skin and subcutaneous tissue

461

2128

1.84

32.03

1.3

1.2

33.02

34.34

mmol/l

0.59

403

1845

Generalized anxiety disorder

101

275

3.70

31.95

1.4

1.3

34.54

35.61

mmol/l

0.14

249

Non-rheumatic valve diseases

301

1000

2.16

31.92

1.1

1.2

35.41

34.42

mmol/l

0.29

264

861

All influenza

192

760

2.55

31.74

1.8

1.3

32.08

35.29

mmol/l

1.14

173

665

Low back pain

444

1603

1.88

31.64

1.3

1.2

32.06

34.71

mmol/l

1.67

384

1422

Diabetes, varying definitions

568

1881

1.76

31.62

1.4

1.3

33.65

34.62

mmol/l

0.45

495

1656

Later onset COPD, excluding more controls

169

465

2.80

31.50

1.1

33.33

36.36

mmol/l

0.96

143

403

Injuries to the thorax

309

1499

2.07

31.48

1.2

1.1

33.47

34.73

mmol/l

0.43

252

1304

Poisoning by medicine

142

483

2.97

31.48

1.5

1.3

27.15

35.85

mmol/l

5.52

127

437

Examination and observation for other reasons

319

842

2.15

31.48

1.5

1.2

37.09

34.71

mmol/l

0.82

281

744

Dysphagia

190

752

2.55

31.46

1.3

1.2

32.57

35.27

mmol/l

0.88

163

648

Poisoning by drugs, medicaments and biological substances

154

548

2.83

31.43

1.5

1.2

27.00

35.36

mmol/l

5.47

136

488

Lower back pain or/and sciatica

613

2238

1.71

31.40

1.2

32.82

34.20

mmol/l

0.75

528

1965

Valvular heart disease excluding rheumatic fever

303

1019

2.14

31.24

1.2

35.40

34.35

mmol/l

0.32

266

880

Invasive ventilation

205

4.18

31.20

1.5

1.3

38.69

34.83

mmol/l

0.64

186

Asthma (only as main-diagnosis)

363

1001

2.03

31.17

1.3

1.2

31.63

35.32

mmol/l

2.21

307

891

Gastroduodenal ulcer

197

797

2.49

30.91

1.3

1.1

33.08

35.85

mmol/l

0.84

164

674

Chronic pancreatitis

114

345

3.35

30.88

1.4

1.1

27.03

34.83

mmol/l

3.35

103

306

Fracture of rib(s), sternum and thoracic spine

229

996

2.32

30.80

1.2

1.1

35.20

35.17

mmol/l

0.01

185

861

Type 1 diabetes, wide definition

153

548

2.81

30.80

1.8

1.4

30.57

35.72

mmol/l

2.31

139

489

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

540

1826

1.76

30.47

1.4

1.2

32.72

34.64

mmol/l

1.18

470

1605

Other diseases of the digestive system

245

1102

2.24

30.42

1.6

1.1

31.85

35.45

mmol/l

1.79

213

938

Asthma-related pneumonia

272

1271

2.15

30.40

1.3

1.2

32.46

35.21

mmol/l

1.34

229

1109

Asthma-related pneumonia or sepsis

272

1273

2.14

30.28

1.3

1.2

32.46

35.21

mmol/l

1.33

229

1111

Asthma, hospital admissions 3, pneumonia

272

1273

2.14

30.28

1.3

1.2

32.46

35.21

mmol/l

1.33

229

1111

Early onset COPD

163

610

2.70

30.28

1.2

31.46

34.88

mmol/l

1.07

141

533

Stroke, excluding SAH

402

1533

1.90

30.25

1.2

34.67

34.50

mmol/l

0.05

345

1327

Erysipelas

346

1516

1.98

30.20

1.2

1.1

33.55

34.75

mmol/l

0.41

297

1322

Organic, including symptomatic, mental disorders

381

1390

1.94

30.18

1.2

31.64

34.95

mmol/l

2.04

324

1191

Diseases of arteries, arterioles and capillaries

439

1754

1.84

30.14

1.2

31.89

35.08

mmol/l

2.33

385

1507

Diabetes mellitus

564

1886

1.73

29.96

1.4

1.3

33.61

34.59

mmol/l

0.46

492

1660

Type 2 diabetes, wide definition

472

1645

1.82

29.95

1.2

33.30

34.83

mmol/l

0.79

413

1428

Nonorganic sleeping disorders, excluding more controls

117

367

3.21

29.80

1.5

1.3

33.65

35.72

mmol/l

0.39

104

323

Hypotension

161

604

2.70

29.80

1.1

33.28

35.00

mmol/l

0.38

127

513

Other and unspecified dermatitis

338

1733

1.96

29.57

1.2

1.3

31.83

34.20

mmol/l

1.21

296

1512

Acute alcohol intoxication, ICD10

144

513

2.83

29.39

1.2

25.95

36.50

mmol/l

7.59

121

463

Vocal cord dysfunction

146

4.49

29.30

1.2

1.3

33.13

36.90

mmol/l

0.64

135

Symptoms and signs involving the nervous and musculoskeletal systems

368

1949

1.90

29.19

1.4

1.3

33.64

34.48

mmol/l

0.27

324

1693

Dermatitis

391

2066

1.86

29.04

1.2

1.3

31.75

34.41

mmol/l

1.64

345

1808

Insulin medication

380

1675

1.89

28.91

1.5

1.2

31.26

35.30

mmol/l

3.34

338

1461

GI-bleeding

241

1102

2.20

28.76

1.6

1.1

31.99

35.48

mmol/l

1.66

207

938

Neuromuscular dysfunction of bladder

209

3.98

28.69

1.7

1.1

32.35

35.99

mmol/l

0.55

181

Fracture of shoulder and upper arm

269

1284

2.11

28.65

1.3

31.95

35.15

mmol/l

1.61

234

1117

Asthma-related infections

372

1938

1.88

28.59

1.3

31.57

34.97

mmol/l

2.54

312

1705

Asthma, hospital admission 2, infections

372

1938

1.88

28.59

1.3

31.57

34.97

mmol/l

2.54

312

1705

Diabetes medication

583

2020

1.69

28.50

1.4

1.3

33.05

34.53

mmol/l

0.85

506

1777

Hard cardiovascular diseases

480

1599

1.78

28.16

1.2

1.3

34.98

33.36

mmol/l

0.76

430

1400

Candidiasis

119

391

3.08

28.14

1.7

1.2

30.14

34.79

mmol/l

1.63

107

342

Pain in limb

480

1728

1.77

28.14

1.3

1.4

33.34

34.26

mmol/l

0.34

409

1529

Certain infectious and parasitic diseases, including avohilmo

372

954

1.96

28.12

1.2

1.3

35.86

34.50

mmol/l

0.47

329

838

Other and unspecified nonorganic psychotic disorders

124

417

3.00

28.11

1.3

1.2

28.65

35.74

mmol/l

2.97

110

377

Infections of the skin and subcutaneous tissue

343

1769

1.92

28.02

1.7

1.3

33.02

34.55

mmol/l

0.59

303

1563

Other CVD

175

705

2.51

28.01

1.1

1.2

33.58

35.15

mmol/l

0.33

140

598

Non-selective monoamine reuptake inhibitors

231

1004

2.22

27.98

1.3

1.1

28.29

35.44

mmol/l

5.84

185

892

Abnormal findings on diagnostic imaging of lung

325

1587

1.95

27.78

1.2

32.14

34.89

mmol/l

1.47

288

1355

Codeine or tramadol medication

605

1978

1.67

27.58

1.3

1.2

33.99

33.96

mmol/l

0.01

505

1744

Problems related to lifestyle

215

3.86

27.56

1.2

1.1

28.10

35.52

mmol/l

2.14

195

Nephropathy related operations

111

358

3.15

27.15

1.6

1.2

30.98

35.57

mmol/l

1.06

105

319

Asthma (diagnoses ohter than nonallergic)

506

2409

1.70

27.04

1.3

31.54

34.40

mmol/l

2.31

431

2129

Gastro-oesophageal reflux disease

396

1840

1.82

26.98

1.3

1.2

32.29

34.69

mmol/l

1.43

349

1606

Other special examinations and investigations of persons without complaint or reported diagnosis

334

847

2.00

26.95

1.2

34.14

34.83

mmol/l

0.19

293

749

Continuous positive airway pressure

107

275

3.26

26.76

1.4

1.5

34.82

37.96

mmol/l

0.58

240

Paroxysmal tachycardia

107

274

3.26

26.74

1.3

1.4

32.99

36.34

mmol/l

0.75

243

Other arrhythmias

338

1315

1.93

26.74

1.2

34.31

33.95

mmol/l

0.10

295

1140

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

230

1065

2.18

26.66

1.6

1.2

32.41

34.45

mmol/l

0.68

206

922

Alcohol abuse, main dg

116

389

3.01

26.49

1.2

26.97

37.03

mmol/l

5.59

348

Asthma (mode)

368

1013

1.91

26.37

1.3

1.2

31.28

35.28

mmol/l

2.64

310

899

Non-ischemic cardiomyopathy

231

839

2.20

26.30

1.2

31.76

34.71

mmol/l

1.15

203

716

Alcohol-induced chronic pancreatitis

137

4.61

26.19

1.3

1.2

25.28

37.46

mmol/l

3.51

126

Neurological diseases, wide definition

131

211

3.13

26.10

1.3

1.7

34.99

37.65

mmol/l

0.49

125

196

Insulin, combination of fast acting with intermediate-acting or long-acting

382

1916

1.82

26.06

1.5

1.2

31.25

35.21

mmol/l

3.35

339

1661

Traumatic subdural haemorrhage

107

322

3.14

25.82

1.2

1.1

34.08

36.76

mmol/l

0.53

278

Other and unspecified myopathies

250

3.54

25.65

1.2

31.47

35.20

mmol/l

0.85

221

Spondylopathies

445

1494

1.77

25.56

1.2

34.05

34.87

mmol/l

0.30

380

1319

Heart failure and bmi 25plus

218

649

2.25

25.34

1.2

1.1

33.97

34.50

mmol/l

0.12

187

541

Other diseases of pleura

307

1386

1.94

25.33

1.4

1.2

33.70

34.91

mmol/l

0.42

269

1192

Hypothyroidism, strict autoimmune

383

1377

1.83

25.32

1.3

1.2

33.39

34.84

mmol/l

0.60

320

1207

Neurological diseases

426

1189

1.80

25.22

1.3

1.4

35.41

35.07

mmol/l

0.10

376

1061

Abdominal and pelvic pain

520

1539

1.70

25.21

1.2

1.3

32.22

35.08

mmol/l

1.98

457

1355

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

156

626

2.51

25.17

1.5

1.2

27.53

35.04

mmol/l

4.00

139

559

Psychotic depression

5.34

25.13

1.1

33.55

36.72

mmol/l

0.41

Disorders of lens

380

1288

1.84

25.04

1.2

33.28

34.20

mmol/l

0.31

341

1132

Diabetes, insulin treatment (Kela reimbursement)

570

2076

1.64

24.95

1.4

1.2

32.65

34.63

mmol/l

1.32

496

1817

Insulin, intermediate and long-acting

343

1804

1.84

24.82

1.5

1.2

30.68

35.27

mmol/l

3.96

303

1559

Gastrointestinal diseases

277

668

2.09

24.79

1.3

35.14

35.49

mmol/l

0.08

249

594

Implicit fungal Sepsis

5.40

24.75

1.6

1.1

31.57

37.12

mmol/l

0.83

Iron deficiency anaemia secondary to blood loss (chronic)

133

499

2.69

24.71

1.6

1.2

32.66

34.54

mmol/l

0.47

118

421

Ascites

201

3.79

24.53

1.3

1.1

35.16

36.39

mmol/l

0.15

175

Accidents

401

1106

1.82

24.49

1.3

33.21

34.97

mmol/l

0.78

351

994

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

105

349

3.04

24.37

1.4

1.2

27.60

35.76

mmol/l

3.39

319

Benign neoplasm of other and unspecified endocrine glands

112

387

2.93

24.33

1.3

1.2

34.50

35.43

mmol/l

0.16

105

336

Candidiasis, including avohilmo

199

903

2.22

24.31

1.5

1.2

29.67

34.80

mmol/l

3.06

171

784

Viral pneumonia

102

335

3.08

24.20

2.7

1.3

30.75

35.82

mmol/l

1.57

300

Heart failure and coronary heart disease

300

1085

1.95

24.18

1.2

33.66

34.09

mmol/l

0.12

264

920

Episodal and paroxysmal disorders

576

1794

1.63

24.04

1.2

1.4

34.21

34.60

mmol/l

0.14

501

1587

Noninfective enteritis and colitis

279

1439

1.95

24.03

2.1

1.3

33.97

34.54

mmol/l

0.14

250

1250

Disorder of lipoprotein metabolism, unspecified

181

3.90

24.01

1.2

1.1

29.91

39.03

mmol/l

2.93

152

Spinal stenosis

326

1283

1.88

24.01

1.1

33.91

34.70

mmol/l

0.26

281

1123

Other external causes of accidental injury

399

1106

1.81

24.00

1.3

32.93

34.97

mmol/l

0.96

349

994

Viral hepatitis, IBD co-morbidity

8.08

23.89

1.7

1.0

40.11

38.01

mmol/l

0.12

Symptoms and signs involving the circulatory and respiratory systems

489

1444

1.70

23.75

1.3

1.4

34.42

34.30

mmol/l

0.03

433

1294

Persons encountering health services for examination and investigation

325

847

1.93

23.67

1.3

1.2

36.07

34.83

mmol/l

0.40

285

749

Artificial opening status

150

4.22

23.40

3.7

1.2

46.96

35.81

mmol/l

2.01

132

Supplementary factors related to causes of morbidity and mortality classified elsewhere

203

949

2.15

23.05

1.4

1.2

34.75

34.69

mmol/l

0.01

182

829

Chronic lower respiratory diseases

637

2139

1.57

23.00

1.3

1.4

32.08

34.55

mmol/l

1.94

545

1897

Unspecified haematuria

258

1059

1.99

22.99

1.3

1.2

34.64

34.96

mmol/l

0.07

218

929

External causes of morbidity and mortality

315

820

1.93

22.98

1.2

1.4

33.05

35.35

mmol/l

1.03

283

729

Type 2 diabetes

509

1797

1.64

22.53

1.2

32.73

34.64

mmol/l

1.11

440

1575

Ischaemic Stroke, excluding all haemorrhages

361

1495

1.79

22.52

1.1

1.2

35.20

34.38

mmol/l

0.26

308

1294

Type of accident

193

896

2.17

22.33

1.5

1.2

35.47

34.72

mmol/l

0.15

172

779

Missing teeth due to accident, extraction or parodontitis

381

1969

1.74

22.32

1.2

31.45

34.30

mmol/l

1.99

321

1713

Disorders of thyroid, IBD co-morbidities

151

3.64

22.31

1.2

34.65

38.82

mmol/l

0.68

136

Other soft tissue disorders, not elsewhere classified

506

1760

1.64

22.09

1.3

1.4

33.08

34.30

mmol/l

0.52

432

1560

Diseases of the myoneural junction and muscle

107

381

2.84

22.05

1.3

33.28

35.49

mmol/l

0.46

336

Mycoses

185

849

2.19

22.04

1.5

1.2

30.41

34.92

mmol/l

2.37

165

744

Gastric ulcer

133

530

2.53

21.90

1.3

1.1

33.62

36.02

mmol/l

0.48

109

447

Other noninfective gastroenteritis and colitis

171

762

2.26

21.86

2.3

1.3

32.73

34.67

mmol/l

0.48

156

662

Follow-up examination after treatment for conditions other than malignant neoplasms

227

729

2.08

21.85

1.3

1.2

34.06

34.52

mmol/l

0.10

198

638

Sequelae of cerebrovascular disease

251

1095

1.97

21.81

1.2

1.1

34.48

35.11

mmol/l

0.15

216

940

Cough

240

1132

1.99

21.79

1.3

1.4

35.06

34.53

mmol/l

0.12

201

1007

Polyuria

149

628

2.39

21.73

1.4

1.1

35.61

35.13

mmol/l

0.08

124

551

608

1973

1.57

21.45

1.3

1.2

33.13

34.30

mmol/l

0.58

524

1737

Hypothyroidism, other/unspecified

472

1894

1.64

21.42

1.4

1.2

33.59

34.64

mmol/l

0.46

403

1659

Polyneuropathies and other disorders of the peripheral nervous system

158

688

2.32

21.41

1.2

32.74

35.38

mmol/l

0.70

140

595

264

1383

1.90

21.31

1.4

31.41

35.26

mmol/l

2.24

224

1216

Pain (limb, back, neck, head abdominally)

373

1055

1.78

21.12

1.2

1.3

35.53

35.55

mmol/l

0.01

331

946

Urinary track infection

286

742

1.94

21.10

1.4

32.48

33.07

mmol/l

0.16

248

645

Bacterial pneumoniae

241

1080

1.97

21.07

1.4

1.2

31.06

35.09

mmol/l

2.15

213

941

Abnormalities of heart beat

206

970

2.07

21.07

1.2

33.84

34.63

mmol/l

0.20

178

855

Suicide or other Intentional self-harm

137

565

2.44

20.96

1.4

1.2

27.24

34.92

mmol/l

4.01

121

504

Polyarthropathies

369

1360

1.75

20.95

1.2

32.15

34.51

mmol/l

1.20

317

1203

Peripheral artery disease

293

1256

1.85

20.91

1.2

1.1

32.01

35.34

mmol/l

1.78

249

1067

Autoimmune diseases related-to ILD

462

2383

1.62

20.89

1.4

1.2

33.31

34.05

mmol/l

0.28

400

2090

Transient ischemic attack

331

1486

1.78

20.89

1.2

1.1

33.75

34.43

mmol/l

0.22

283

1287

Mental and behavioural disorders due to sedatives or hypnotics

141

4.10

20.87

1.5

1.2

26.49

38.08

mmol/l

3.32

131

Superficial injury of head

168

759

2.23

20.78

1.3

32.78

34.94

mmol/l

0.53

138

660

Sciatica+with lumbago

290

1402

1.84

20.68

1.2

33.66

34.57

mmol/l

0.26

249

1247

Pneumonitis due to solids and liquids

231

3.34

20.61

1.5

1.2

32.54

35.84

mmol/l

0.63

200

Other headache syndromes

233

1190

1.96

20.61

1.3

1.2

34.63

33.67

mmol/l

0.24

205

1043

Exclusions for E4_PCOS_CONSORTIUM

395

1447

1.71

20.60

1.5

1.3

34.62

33.68

mmol/l

0.32

345

1269

Ischaemic heart disease, wide definition

435

1616

1.66

20.41

1.1

35.70

33.58

mmol/l

1.03

377

1405

Disorders of the thyroid gland

493

1997

1.61

20.39

1.4

1.2

33.45

34.61

mmol/l

0.54

423

1755

Bronchitis

585

2273

1.55

20.36

1.3

1.2

32.78

34.14

mmol/l

0.72

510

1991

Diverticular disease of intestine

397

1458

1.70

20.33

1.2

1.1

33.18

34.65

mmol/l

0.60

334

1273

Hypothyreosis and Thyroxine purchase for inclusion criteria

489

2000

1.61

20.28

1.4

1.2

33.46

34.44

mmol/l

0.43

416

1748

Sub-endpoint used in defining T1D endpoints

181

837

2.14

20.27

1.8

1.3

30.22

35.60

mmol/l

3.11

166

719

Ischemic heart diseases

461

1684

1.63

20.14

1.2

1.3

36.48

33.18

mmol/l

2.08

407

1471

Injuries to the hip and thigh

314

1590

1.78

20.11

1.3

1.2

34.72

34.48

mmol/l

0.06

263

1371

L04AX Other immunosuppressants

317

1806

1.76

20.00

1.4

1.3

31.84

34.22

mmol/l

1.13

274

1586

Schizophrenia

102

373

2.76

19.99

1.4

1.2

27.43

36.36

mmol/l

4.05

336

Genitourinary diseases

278

731

1.91

19.84

1.4

1.5

37.29

35.87

mmol/l

0.39

263

662

COPD, hospital admissions 1, only main diagnosis

225

987

1.97

19.67

1.2

1.1

34.24

35.08

mmol/l

0.21

189

842

COPD-related respiratory insufficiency

344

2.82

19.60

1.2

1.1

34.17

35.28

mmol/l

0.17

297

Bacterial pneumonia, not elsewhere classified

229

1035

1.95

19.59

1.4

1.2

31.74

35.36

mmol/l

1.73

202

902

Other and unspecified polyneuropathies, also in other diseases

139

596

2.35

19.58

1.2

1.1

33.43

35.23

mmol/l

0.37

123

516

Other acute lower respiratory infections

313

1700

1.76

19.58

1.8

1.3

34.24

34.68

mmol/l

0.12

275

1478

Volvulus

5.50

19.58

1.7

1.1

29.97

38.82

mmol/l

1.63

Other diseases of blood and blood-forming organs, wide

156

703

2.24

19.53

1.6

1.2

31.65

34.37

mmol/l

0.95

142

610

Leisure time condition

127

528

2.43

19.17

1.4

1.2

35.30

35.46

mmol/l

0.02

109

470

Fracture of skull and facial bones

131

553

2.39

19.09

1.3

1.2

30.83

35.88

mmol/l

1.57

113

488

Dermatitis and eczema

600

2347

1.52

19.08

1.3

31.42

34.47

mmol/l

2.79

520

2066

Viral and other specified intestinal infections, including avohilmo

152

656

2.24

19.07

2.1

1.5

32.80

35.22

mmol/l

0.59

143

578

Second line medication for Crohn's disease

320

1853

1.73

19.06

1.4

1.3

31.83

34.11

mmol/l

1.07

277

1629

Fibrosis and cirrhosis of liver

218

3.31

18.99

1.1

1.2

35.86

34.58

mmol/l

0.16

189

Intestinal adhesions without obstruction

228

3.24

18.97

1.9

1.2

35.53

35.57

mmol/l

0.00

201

Bipolar affective disorders

356

2.74

18.88

1.2

24.30

36.33

mmol/l

7.40

317

296

2.93

18.88

1.8

1.1

34.56

35.71

mmol/l

0.15

254

Other degenerative diseases of the nervous system

167

557

2.20

18.87

1.2

32.04

36.54

mmol/l

1.65

139

487

Diseases of the eye and adnexa

361

1047

1.73

18.84

1.3

1.4

34.64

34.30

mmol/l

0.09

324

943

Panic disorder

240

3.15

18.67

1.2

31.02

36.64

mmol/l

1.25

215

Atherosclerosis, excluding cerebral and coronary sclerosis

272

1175

1.83

18.66

1.2

1.1

32.16

35.56

mmol/l

1.67

231

996

Neoplasms

352

1069

1.73

18.57

1.4

1.6

35.35

33.50

mmol/l

0.70

325

948

Other bacterial intestinal infections, including avohilmo

157

725

2.18

18.52

1.6

1.2

33.15

35.14

mmol/l

0.51

140

614

Diseases of the respiratory system

317

893

1.78

18.30

1.2

34.43

35.60

mmol/l

0.37

277

790

Glomerular diseases

125

529

2.38

18.17

1.3

1.2

28.38

36.46

mmol/l

4.85

116

462

Senile cataract

339

1201

1.72

18.14

1.2

1.1

33.01

33.99

mmol/l

0.32

303

1047

Nontraumatic intracranial haemmorrhage

145

656

2.23

18.01

1.2

1.1

31.23

35.04

mmol/l

1.33

125

552

Coronary atherosclerosis

367

1385

1.68

17.98

1.1

36.25

33.51

mmol/l

1.37

319

1193

Explicit bacterial Sepsis, including avohilmo

268

2.98

17.83

1.7

1.2

32.09

36.64

mmol/l

0.98

229

Ulcer of lower limb, not elsewhere classified

112

455

2.49

17.83

1.3

1.1

31.85

35.01

mmol/l

0.76

384

Vascular disorders of the intestines

177

3.49

17.83

1.2

1.1

37.35

37.71

mmol/l

0.03

154

Factors influencing health status and contact with health services

133

270

2.48

17.81

1.3

1.2

38.15

38.05

mmol/l

0.02

121

247

Other bacterial intestinal infections

129

559

2.33

17.77

1.7

1.2

32.98

35.73

mmol/l

0.70

117

469

L04AA Selective immunosuppressants

142

641

2.23

17.75

1.6

1.2

29.84

35.09

mmol/l

1.95

126

560

Periodontitis

521

2170

1.53

17.73

1.2

31.23

34.44

mmol/l

2.76

447

1906

Other cataract

255

1035

1.84

17.72

1.2

33.95

34.52

mmol/l

0.15

224

902

Malnutrition

5.05

17.71

1.9

1.4

31.43

33.94

mmol/l

0.25

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

135

591

2.27

17.58

2.0

1.7

36.00

34.56

mmol/l

0.24

122

531

Other dorsopathies, not elsewhere classified

497

1657

1.56

17.57

1.2

1.3

33.59

34.70

mmol/l

0.45

421

1475

Explicit bacterial Sepsis

260

2.99

17.53

1.5

1.2

32.03

36.77

mmol/l

1.01

223

Asthma/COPD (KELA code 203)

493

2137

1.54

17.52

1.2

1.4

33.19

34.53

mmol/l

0.66

419

1895

Other mental disorders due to brain damage and dysfunction and to physical disease

383

2.61

17.48

1.2

1.1

31.67

35.05

mmol/l

0.67

324

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

124

3.59

17.36

1.3

1.1

35.19

37.57

mmol/l

0.31

111

Nerve, nerve root and plexus disorders

550

2191

1.51

17.29

1.2

31.82

34.67

mmol/l

2.22

467

1922

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

226

3.13

17.25

1.4

1.2

32.43

35.98

mmol/l

0.64

200

Dorsalgia

484

1645

1.56

17.25

1.3

33.52

34.72

mmol/l

0.50

420

1463

Chronic periodontitis, including avohilmo

518

2173

1.52

17.18

1.1

1.2

31.40

34.39

mmol/l

2.44

444

1911

Other gastritis (incl. Duodenitis)

144

664

2.18

17.10

1.4

1.1

29.94

35.30

mmol/l

2.16

131

561

Persons encountering health services for specific procedures, not carried out

182

3.39

17.08

2.0

1.2

29.80

34.74

mmol/l

0.94

165

severe traumatic brain injury, does not include concussion

151

711

2.14

17.00

1.2

36.36

35.37

mmol/l

0.17

122

603

Bacterial pneumonia (organism specified)

264

1351

1.78

17.00

1.4

1.2

31.46

35.08

mmol/l

2.01

234

1165

Other retinal disorders

382

1798

1.62

16.96

1.1

1.2

31.56

34.79

mmol/l

2.22

325

1551

Cirrhosis of liver, NAS

145

3.72

16.96

1.1

1.2

38.64

35.61

mmol/l

0.35

130

Other symptoms and signs involving the nervous and musculoskeletal systems

238

1312

1.82

16.94

1.3

35.05

34.35

mmol/l

0.16

214

1143

Other diseases of liver

118

505

2.35

16.76

1.3

1.2

32.77

34.97

mmol/l

0.55

112

440

Other/unspecified dorsalgia

207

1084

1.89

16.63

1.3

1.2

33.62

35.04

mmol/l

0.41

184

948

Spondylosis

304

1398

1.71

16.56

1.2

1.1

33.79

34.75

mmol/l

0.31

262

1231

Phobic anxiety disorders

200

3.21

16.53

1.5

1.6

35.69

36.97

mmol/l

0.13

186

Molar incisor enamel hypoplasia, with caries

6.52

16.50

1.6

3.5

26.04

43.07

mmol/l

2.46

Other disorders of glucose regulation and pancreatic internal secretion

222

3.10

16.47

1.6

1.3

30.12

36.70

mmol/l

1.64

205

Undetermined asthma, excluding more controls

264

2.90

16.43

1.3

1.1

34.32

37.63

mmol/l

0.68

235

Hypoplasia of dental enamel

5.87

16.39

2.4

3.2

24.23

38.26

mmol/l

2.15

ILD medications: azathioprine

350

2.62

16.25

1.7

1.3

30.05

35.58

mmol/l

1.13

310

Other (not insulin) diabetes medications

495

1912

1.52

16.12

1.2

32.94

34.56

mmol/l

0.88

430

1673

Any event in cancer register

451

1698

1.55

16.10

1.3

33.94

33.17

mmol/l

0.29

406

1469

Collagenous colitis

263

2.89

16.03

1.8

1.2

31.60

35.19

mmol/l

0.61

231

Type 2 diabetes, definitions combined

466

1763

1.54

16.01

1.2

33.70

34.66

mmol/l

0.40

400

1543

Major coronary heart disease event excluding revascularizations

346

1392

1.65

16.00

1.2

1.1

35.29

34.05

mmol/l

0.43

293

1195

Fracture of femur

201

962

1.89

15.90

1.2

33.47

34.96

mmol/l

0.40

171

814

Enterocolitis due to Clostridium difficile

320

2.68

15.88

1.6

1.2

30.88

35.35

mmol/l

1.38

272

Chronic gastritis

173

879

1.98

15.88

1.2

1.1

30.43

35.20

mmol/l

1.94

146

741

Malignant neoplasm, wide definition

441

1652

1.56

15.88

1.3

1.2

34.13

33.08

mmol/l

0.43

397

1429

Angina pectoris

321

1277

1.67

15.84

1.1

34.80

33.72

mmol/l

0.34

272

1095

Respiratory insufficiency

176

3.32

15.75

1.9

1.3

28.97

36.92

mmol/l

1.96

161

Other complications of surgical and medical care, not elsewhere classified

244

2.94

15.73

2.6

1.2

34.41

35.78

mmol/l

0.17

218

Presence of other functional implants

348

1464

1.63

15.73

1.3

1.1

31.18

34.56

mmol/l

2.29

292

1272

Type 2 diabetes, strict (exclude DM1)

468

1782

1.53

15.64

1.2

33.75

34.66

mmol/l

0.37

402

1557

Any dementia, excluding more controls

224

836

1.85

15.63

1.1

32.90

35.84

mmol/l

1.14

188

715

Acute bronchitis

243

1354

1.77

15.63

1.7

1.3

33.79

34.67

mmol/l

0.24

208

1169

Cellulitis

141

671

2.12

15.50

1.4

1.2

33.68

34.76

mmol/l

0.22

125

597

Injuries to the shoulder and upper arm

464

2370

1.51

15.48

1.3

1.2

31.71

34.54

mmol/l

2.05

402

2078

Aneurysms, operations, SAH

112

486

2.32

15.46

1.2

1.1

30.26

35.11

mmol/l

1.78

419

Malignant neoplasm, including Hilmo

438

1651

1.55

15.40

1.2

34.19

33.08

mmol/l

0.46

394

1428

Pleural effusion

112

487

2.32

15.40

1.2

1.1

35.41

35.27

mmol/l

0.02

101

422

Dorsopathies

501

1682

1.51

15.31

1.2

1.4

33.33

34.71

mmol/l

0.63

436

1500

Type 2 diabetes, definitions combined, including avohilmo

465

1765

1.53

15.31

1.2

33.76

34.70

mmol/l

0.39

400

1547

Use of disulfiram, acamprosate or naltrexone

185

3.22

15.30

1.3

1.2

27.54

37.26

mmol/l

2.55

172

Bacterial intestinal infections, IBD co-morbidities

129

598

2.17

15.19

1.7

1.2

33.01

35.48

mmol/l

0.62

118

505

Cutaneous abscess, furuncle and carbuncle

148

723

2.06

15.17

1.6

1.3

32.18

34.68

mmol/l

0.79

134

644

Sequelae of external causes of morbidity and mortality

162

819

1.99

15.12

1.4

1.2

29.53

35.17

mmol/l

2.81

144

713

Azathioprine

364

2.52

15.03

1.7

1.3

30.05

35.73

mmol/l

1.19

324

Disorders of gallbladder, biliary tract and pancreas

512

2151

1.48

14.98

1.5

1.2

33.49

34.35

mmol/l

0.36

441

1882

Percutaneous Coronary Intervention

418

1644

1.55

14.91

1.2

1.3

36.11

33.13

mmol/l

1.69

372

1437

Lung cancer and mesothelioma

113

419

2.30

14.84

1.1

34.74

37.37

mmol/l

0.61

103

364

Hernia

488

2179

1.49

14.80

1.4

1.2

34.79

33.62

mmol/l

0.55

432

1905

Other general symptoms and signs

4.28

14.79

1.2

2.1

33.06

35.88

mmol/l

0.21

Chronic periodontitis, complicated

309

1853

1.63

14.77

1.1

1.2

29.96

34.43

mmol/l

3.81

272

1609

Fall on and from stairs and steps

160

813

1.98

14.73

1.2

29.94

35.49

mmol/l

2.46

131

702

Hypothyroidism, strict autoimmune, 3 medication purchases required

426

1873

1.53

14.69

1.2

32.49

34.07

mmol/l

0.78

356

1635

Viral and other specified intestinal infections

110

472

2.29

14.64

2.5

1.6

33.48

36.45

mmol/l

0.58

103

422

Injury, poisoning and certain other consequences of external causes

242

675

1.80

14.57

1.3

1.5

33.31

35.58

mmol/l

0.82

221

601

Malignant neoplasm

428

1636

1.54

14.56

1.2

34.31

33.10

mmol/l

0.52

384

1416

Other inflammatory liver diseases

152

3.40

14.38

1.5

1.2

28.80

35.49

mmol/l

1.58

134

Other diseases of anus and rectum

179

949

1.89

14.35

1.3

1.1

31.32

35.34

mmol/l

1.65

144

824

Unspecified kidney failure

314

2.61

14.32

1.5

1.2

29.74

35.43

mmol/l

1.56

259

Assault

257

2.78

14.32

1.5

1.3

31.74

37.74

mmol/l

0.96

241

Personality disorders

124

580

2.15

14.27

1.4

1.2

27.97

34.80

mmol/l

2.99

104

516

Injuries to the elbow and forearm

385

2146

1.54

14.25

1.5

1.3

32.97

34.02

mmol/l

0.42

323

1890

Disorders of adult personality and behaviour

130

620

2.11

14.23

1.4

1.3

29.68

34.61

mmol/l

1.71

108

551

Acute pancreatitis

121

563

2.16

14.14

1.4

1.1

31.26

34.96

mmol/l

1.10

104

495

Major coronary heart disease event

448

1780

1.51

14.13

1.2

1.3

35.63

33.36

mmol/l

1.19

399

1551

Malignant neoplasm

425

1633

1.53

14.13

1.2

34.28

33.10

mmol/l

0.50

381

1413

Hypoglycaemia, other or unspecified

179

3.17

14.11

1.7

1.3

31.53

37.46

mmol/l

1.16

165

Undetermined asthma

287

2.66

14.10

1.3

1.1

34.32

37.28

mmol/l

0.60

257

Peripheral arterial reconstruction

117

538

2.19

14.10

1.1

29.54

35.51

mmol/l

2.68

453

Disorders of parathyroid gland

144

709

2.02

14.03

1.2

1.1

33.27

33.81

mmol/l

0.10

135

588

Nonorganic sleeping disorders

117

539

2.18

14.01

1.5

1.3

33.65

34.99

mmol/l

0.24

104

480

Hepatic failure, not elsewhere classified

4.19

13.98

1.3

1.2

33.31

35.10

mmol/l

0.17

Pain associated with micturition

324

2.55

13.95

1.3

1.2

31.42

34.74

mmol/l

0.61

290

Dental caries, including avohilmo

383

1253

1.57

13.92

1.3

33.98

34.86

mmol/l

0.32

331

1102

Budesonide

342

2.50

13.90

1.8

1.1

34.16

34.89

mmol/l

0.08

302

Insulin, fast-acting (human)

309

2.57

13.71

1.1

1.2

28.64

35.58

mmol/l

2.51

280

Coronary revascularization (ANGIO or CABG)

412

1645

1.53

13.71

1.2

1.3

35.99

33.15

mmol/l

1.54

366

1438

Benign neoplasms

463

1696

1.49

13.46

1.3

1.4

35.20

34.24

mmol/l

0.34

403

1499

Subarachnoid haemorrhage

295

2.60

13.43

1.2

30.37

34.67

mmol/l

1.06

252

Emergency coronary revascularization (for ACS)

459

1872

1.48

13.40

1.2

36.01

33.45

mmol/l

1.47

405

1626

Disorders of choroid and retina

435

2047

1.49

13.37

1.1

1.2

32.40

34.38

mmol/l

1.12

373

1778

Somatoform disorder

373

2.40

13.34

1.4

1.2

33.53

34.41

mmol/l

0.15

326

Other nutritional deficiencies

325

1892

1.57

13.32

1.2

1.3

31.69

34.06

mmol/l

1.14

279

1672

Behavioural syndromes associated with physiological disturbances and physical factors

474

2196

1.46

13.19

1.3

31.88

34.09

mmol/l

1.31

414

1932

Liquid cancers, including Hilmo

217

1103

1.74

13.14

1.2

33.97

33.87

mmol/l

0.02

197

936

Acute and transient psychotic disorders

270

2.65

13.07

1.1

1.2

28.34

36.68

mmol/l

2.90

241

Streptococcal septicaemia, including avohilmo

242

2.75

13.05

1.8

1.2

30.72

36.94

mmol/l

1.56

216

Other diseases of intestine

433

2.28

13.04

2.2

1.1

36.22

35.31

mmol/l

0.13

378

Colectomy operation

114

536

2.14

13.04

2.4

1.1

35.77

34.55

mmol/l

0.20

107

460

Mycoses, including avohilmo

463

2423

1.46

12.90

1.4

1.2

31.52

34.14

mmol/l

1.93

399

2138

Other and unspecified injuries of head

200

2.93

12.86

1.2

36.40

36.32

mmol/l

0.01

177

Other respiratory disorders and diseases

132

660

2.01

12.80

1.6

1.2

30.77

35.74

mmol/l

1.71

111

567

Other diseases of the respiratory system

132

660

2.01

12.80

1.6

1.2

30.77

35.74

mmol/l

1.71

111

567

Myalgia

128

633

2.03

12.78

1.2

32.27

34.14

mmol/l

0.43

112

553

Lung diseases due to external agents

426

2.27

12.67

1.5

1.1

32.34

35.57

mmol/l

0.76

366

Streptococcal septicaemia

235

2.75

12.64

1.5

1.2

30.59

37.09

mmol/l

1.59

209

Diseases of pulp and periapical tissues, including avohilmo

523

1888

1.44

12.53

1.3

33.70

34.87

mmol/l

0.55

449

1670

Other and unspecified drugs and medicaments

225

2.79

12.53

1.5

1.2

32.93

35.49

mmol/l

0.38

200

Systemic connective tissue disorders

207

1202

1.73

12.51

1.3

1.2

32.30

34.16

mmol/l

0.61

181

1018

Diseases of the skin and subcutaneous tissue

466

1597

1.47

12.43

1.2

1.3

34.26

34.65

mmol/l

0.13

396

1417

Other systemic involvement of connective tissue (FG)

153

798

1.89

12.38

1.3

1.2

32.88

34.74

mmol/l

0.48

134

693

Other specified and unspecified personality disorders

167

3.08

12.37

1.7

1.1

27.11

38.00

mmol/l

2.55

155

Vitamin B12 deficiency anaemia

296

2.52

12.33

1.6

1.1

30.57

34.80

mmol/l

0.69

251

Later onset COPD

181

807

1.81

12.32

1.1

33.06

35.58

mmol/l

0.88

153

678

Myocardial infarction

275

1189

1.62

12.29

1.2

36.29

33.88

mmol/l

0.85

232

1015

Functional dyspepsia

142

740

1.93

12.23

1.3

1.2

32.35

34.82

mmol/l

0.67

123

630

Biguanides

477

1997

1.44

12.23

1.1

1.2

33.01

34.41

mmol/l

0.71

406

1747

Acute pancreatitis (for exclusion)

121

598

2.04

12.15

1.4

1.2

31.26

35.58

mmol/l

1.39

104

521

Coagulation defects, purpura and other haemorrhagic conditions

117

572

2.06

12.09

1.8

1.2

34.55

35.04

mmol/l

0.07

105

506

Agranulocytosis

329

2.42

12.09

1.9

1.3

33.00

33.54

mmol/l

0.08

290

Asthma, hospital admissions , main diagnosis only

411

2448

1.46

11.97

1.3

1.4

32.28

34.19

mmol/l

1.03

352

2158

Other disorders of lacrimal gland

205

1203

1.71

11.95

1.3

1.2

32.11

33.75

mmol/l

0.56

181

1035

Specific personality disorders

103

482

2.15

11.93

1.5

1.2

27.65

34.94

mmol/l

2.88

430

Disorders of eyelid, lacrimal system and orbit

443

2246

1.45

11.91

1.2

33.45

33.93

mmol/l

0.18

389

1956

Liquid cancers

181

970

1.77

11.87

1.2

34.08

33.97

mmol/l

0.02

166

823

Glomerular disorders in diseases classified elsewhere

327

2.41

11.77

1.1

1.2

28.02

35.44

mmol/l

3.00

288

Amputation

298

2.47

11.67

1.3

1.1

32.13

35.44

mmol/l

0.69

257

Solid cancers, including Hilmo

411

1627

1.47

11.67

1.2

33.58

33.11

mmol/l

0.16

369

1407

Symptoms and signs involving the skin and subcutaneous tissue

369

2355

1.48

11.65

1.4

1.2

33.45

33.94

mmol/l

0.15

321

2060

Asthma, including avohilmo

581

2317

1.38

11.48

1.3

1.4

31.64

34.56

mmol/l

2.43

496

2050

Open wound of lower leg

464

2.15

11.47

1.3

31.98

35.64

mmol/l

0.91

406

Congenital malformations, deformations and chromosomal abnormalities

259

1545

1.59

11.37

1.8

1.3

34.89

33.79

mmol/l

0.28

226

1365

Sequelae with surgical and medical care as external cause

127

655

1.95

11.34

1.4

1.1

29.09

35.25

mmol/l

2.70

112

571

Lack of expected normal physiological development

5.22

11.29

4.7

29.10

44.46

mmol/l

1.84

Solid cancers

402

1607

1.47

11.24

1.2

33.57

33.14

mmol/l

0.14

360

1387

Abnormal findings on examination of blood, without diagnosis

249

1409

1.60

11.18

1.3

1.2

32.19

35.02

mmol/l

1.06

221

1219

Mental and behavioural disorders due to tobacco

205

2.76

11.17

1.3

1.2

28.30

36.94

mmol/l

2.67

187

Lichen simplex chronicus and prurigo

162

3.00

11.11

1.1

1.2

24.94

36.63

mmol/l

4.10

145

Sleep disorders (combined)

540

2027

1.39

11.09

1.3

1.2

32.50

34.42

mmol/l

1.18

467

1786

Smoking dependency

206

2.74

11.07

1.3

1.2

28.30

36.65

mmol/l

2.53

187

Familial hypercholesterolemia

223

2.66

11.04

1.1

31.49

38.08

mmol/l

1.47

183

Other disorders of bladder

288

2.45

11.02

1.1

40.68

36.89

mmol/l

0.46

253

Fracture of forearm

303

1786

1.53

11.00

1.4

1.2

32.30

33.86

mmol/l

0.66

261

1574

Cervicalgia

111

553

2.02

10.94

1.2

1.1

32.15

35.40

mmol/l

0.93

102

486

Post-traumatic stress disorder

103

3.52

10.85

3.3

1.4

33.21

34.53

mmol/l

0.09

Other diseases of lip and oral mucosa

220

1358

1.63

10.62

1.2

31.30

34.39

mmol/l

1.39

189

1187

Cardiomyopathy

460

2.10

10.52

1.4

1.2

36.37

35.26

mmol/l

0.17

391

Acute upper respiratory infections of multiple and unspecified sites

372

1862

1.46

10.52

1.3

32.21

33.86

mmol/l

0.71

324

1628

Emotionally unstable personality disorder

190

2.75

10.41

1.7

1.2

26.67

36.81

mmol/l

2.93

172

Caries of dentine, including avohilmo

391

1370

1.46

10.40

1.2

1.4

34.70

34.83

mmol/l

0.04

336

1213

Speech disturbances, not elsewhere classified

260

2.49

10.40

1.3

1.2

35.41

34.47

mmol/l

0.10

226

Gingivitis and periodontal diseases

489

1805

1.40

10.38

1.2

1.3

33.72

34.57

mmol/l

0.32

416

1598

Diabetic maculopathy, excluding more controls

260

2.48

10.38

1.1

28.25

35.88

mmol/l

2.61

227

Superficial injury of hip and thigh

476

2.07

10.38

1.3

1.1

33.96

34.93

mmol/l

0.14

404

Diseases of pulp and periapical tissues and dental caries

328

1113

1.51

10.38

1.3

33.98

35.31

mmol/l

0.51

285

976

Unknown and unspecified causes of morbidity

112

3.33

10.25

1.4

1.2

31.37

35.28

mmol/l

0.56

Chronic apical periodontitis

525

2144

1.37

10.14

1.3

1.2

33.08

34.27

mmol/l

0.57

439

1889

Diaphragmatic hernia

205

1259

1.64

10.14

1.3

1.2

35.04

33.96

mmol/l

0.28

181

1078

All influenza (not pneumonia)

356

2.23

10.13

1.5

1.2

32.23

36.20

mmol/l

0.80

322

Injuries to the ankle and foot

332

1927

1.47

10.13

1.3

1.4

33.15

33.94

mmol/l

0.25

290

1709

Diabetic nephropathy, excluding more controls

354

2.13

10.11

1.2

28.40

34.99

mmol/l

2.70

303

Disorders of lacrimal system

239

1498

1.57

10.10

1.2

31.62

33.70

mmol/l

0.90

211

1292

Other intervertebral disc disorders

374

1536

1.45

10.03

1.2

32.97

34.55

mmol/l

0.75

323

1359

Calcific aortic valvular stenosis

186

1075

1.67

10.00

1.1

35.41

35.09

mmol/l

0.07

159

908

Calcific aortic valvular stenosis, operated

186

1075

1.67

10.00

1.1

35.41

35.09

mmol/l

0.07

159

908

Other diseases of hard tissues of teeth

284

953

1.55

9.94

1.2

35.07

34.77

mmol/l

0.07

242

849

Other diseases of pancreas

248

2.48

9.92

1.3

1.1

26.96

33.65

mmol/l

1.76

219

Obesity related asthma

172

1016

1.70

9.89

1.2

31.25

35.21

mmol/l

1.80

147

898

Duodenal ulcer

297

2.34

9.88

1.3

1.1

32.78

35.61

mmol/l

0.50

260

Vitamin deficiency

115

3.26

9.87

1.5

1.2

26.83

36.09

mmol/l

1.65

106

Vitamin deficiency, wide

115

3.26

9.87

1.5

1.2

26.83

36.09

mmol/l

1.65

106

Transport accidents

194

977

1.66

9.86

1.5

1.3

35.91

35.16

mmol/l

0.14

174

876

Non-allergic asthma (mode), excluding more controls

421

2.10

9.86

1.3

34.99

36.96

mmol/l

0.32

371

Elevated blood glucose level

225

2.56

9.85

1.5

1.2

28.77

34.99

mmol/l

1.24

205

Diagnoses used for exclusion with ILD

141

789

1.80

9.82

1.4

1.2

32.04

35.44

mmol/l

1.14

122

676

Soft tissue disorders

481

1774

1.39

9.79

1.3

1.4

35.45

34.25

mmol/l

0.48

424

1574

Unstable angina pectoris

210

1019

1.63

9.78

1.2

1.1

35.06

34.11

mmol/l

0.21

170

865

Calcific aortic valvular stenosis, including rheumatic fever

185

1074

1.66

9.75

1.1

35.22

35.30

mmol/l

0.02

158

907

Finngen Rheumatological endpoints

423

1700

1.41

9.69

1.2

33.46

34.35

mmol/l

0.33

373

1510

Operations 2 for CAVS

184

1070

1.66

9.68

1.1

35.26

35.11

mmol/l

0.03

157

903

Calcific aortic valvular stenosis, diagnosis (helper)

184

1070

1.66

9.68

1.1

35.26

35.11

mmol/l

0.03

157

903

Abnormal weight loss

288

2.35

9.65

1.4

1.2

27.05

36.25

mmol/l

3.31

253

Deforming dorsopathies

145

822

1.77

9.65

1.2

1.3

30.89

35.33

mmol/l

1.71

125

727

Peripheral artery operations in Hilmo

371

2.17

9.59

1.2

28.81

36.33

mmol/l

2.97

311

Traumatic subarachnoid haemorrhage

3.66

9.56

1.2

1.1

35.68

34.73

mmol/l

0.07

Glomerulonephritis

271

2.38

9.53

1.4

1.3

26.97

35.50

mmol/l

3.03

245

Dental operations

304

1038

1.51

9.53

1.2

34.87

35.14

mmol/l

0.07

258

919

Sleep disorders

430

2123

1.40

9.52

1.2

31.77

33.83

mmol/l

1.18

377

1865

Other viral diseases, not elsewhere classified

498

1.99

9.47

2.3

1.5

36.09

35.78

mmol/l

0.04

449

Disturbances of skin sensation

133

740

1.80

9.45

1.4

1.2

36.04

34.62

mmol/l

0.23

116

649

Malignant neoplasm of head and neck

230

2.50

9.42

1.3

1.2

29.12

33.65

mmol/l

0.92

201

Weight loss

310

2.28

9.42

1.4

1.2

26.68

36.09

mmol/l

3.66

274

Focal brain injury

129

3.05

9.38

1.1

1.2

40.36

36.27

mmol/l

0.29

115

Fall on same level involving ice and snow

294

1992

1.48

9.36

1.3

1.2

33.62

34.06

mmol/l

0.13

259

1731

Sequelae of injuries of head

114

3.19

9.33

1.3

1.2

39.47

35.84

mmol/l

0.25

106

Intracerebral haemorrhage

402

2.10

9.32

1.2

1.1

32.02

34.97

mmol/l

0.61

334

Other symptoms and signs involving the urinary system

274

2.35

9.31

1.2

33.28

35.70

mmol/l

0.38

246

Other systemic involvement of connective tissue

156

914

1.71

9.29

1.3

1.2

32.67

34.55

mmol/l

0.50

137

770

Visual disturbances

253

1667

1.52

9.27

1.3

1.2

33.68

34.41

mmol/l

0.19

217

1449

Visual disturbances and blindness

276

1850

1.49

9.26

1.3

33.06

34.39

mmol/l

0.43

237

1610

Inflammatory diseases of the central nervous system

209

2.56

9.20

1.3

1.2

35.77

35.44

mmol/l

0.03

191

Osteonecrosis

153

2.84

9.12

1.3

1.1

29.98

34.75

mmol/l

0.76

136

Fentanyl

276

2.33

9.11

1.7

1.1

34.45

34.86

mmol/l

0.05

230

Benign neoplasm of colon, rectum, anus and anal canal

340

2009

1.43

9.02

1.2

1.1

32.54

34.40

mmol/l

0.76

299

1733

Reimbursement for rheumatic diseases

286

1931

1.48

9.02

1.2

31.43

34.14

mmol/l

1.43

242

1681

Migraine with aura

101

524

1.93

8.93

1.3

1.5

30.87

35.52

mmol/l

1.15

463

Symptoms and signs involving speech and voice

176

1076

1.64

8.93

1.2

34.79

34.61

mmol/l

0.03

149

927

Myocardial infarction, without ST-elevation

228

1333

1.55

8.91

1.2

1.1

36.57

34.52

mmol/l

0.57

194

1138

Erosion of teeth , including avohilmo

122

674

1.82

8.90

1.5

1.3

31.21

35.07

mmol/l

1.05

107

600

Fracture of lower leg, including ankle

280

1865

1.48

8.88

1.3

30.75

34.33

mmol/l

2.01

230

1636

Persistent mood disorders

464

1.99

8.86

1.4

1.2

30.76

36.13

mmol/l

1.56

402

Schizoaffective disorder

150

2.82

8.84

1.2

1.1

27.31

38.74

mmol/l

2.98

139

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

276

1699

1.48

8.83

1.3

35.26

33.72

mmol/l

0.46

239

1498

Presence of cardiac and vascular implants and grafts

242

1164

1.53

8.78

1.1

33.62

35.32

mmol/l

0.57

213

1004

Decubitus ulcer and pressure area

179

2.65

8.78

1.4

1.1

28.82

36.44

mmol/l

2.08

154

Dipeptidyl peptidase 4 (DPP-4) inhibitors

297

1593

1.47

8.76

1.1

31.56

34.79

mmol/l

1.96

259

1379

Diseases of oral cavity, salivary glands and jaws

281

964

1.51

8.74

1.2

35.35

34.90

mmol/l

0.12

239

856

Disorders of ocular muscles, binocular movement, accommodation and refraction

221

1422

1.54

8.68

2.0

1.4

34.18

34.35

mmol/l

0.03

193

1264

Persistent delusional disorders

192

2.58

8.65

1.1

19.41

35.53

mmol/l

7.03

168

Inflammatory bowel disease

147

865

1.71

8.64

1.8

1.2

35.51

34.62

mmol/l

0.15

132

762

Other disorders of ear

452

2145

1.36

8.61

1.3

32.75

34.44

mmol/l

0.94

396

1877

Other viral hepatitis, including avohilmo

120

3.02

8.58

1.6

1.2

39.35

36.42

mmol/l

0.21

112

Other viral diseases

134

770

1.74

8.47

2.0

1.6

34.10

34.94

mmol/l

0.14

123

690

Cerebral palsy and other paralytic syndromes

312

2.20

8.44

3.3

1.3

36.50

35.81

mmol/l

0.08

281

Complications of internal orthopaedic prosthetic devices, implants and grafts

133

767

1.74

8.44

1.2

1.1

33.74

35.18

mmol/l

0.33

115

655

Any dementia

242

1104

1.52

8.38

1.1

33.02

35.17

mmol/l

0.80

203

936

Eating disorders

177

2.61

8.38

2.2

1.4

26.73

35.18

mmol/l

1.83

168

5-aminosalicylic acid

516

1.91

8.35

1.9

1.2

34.34

34.94

mmol/l

0.08

460

Abnormalities of gait and mobility

387

2.06

8.30

1.3

1.2

31.57

34.42

mmol/l

0.59

338

Persons with potential health hazards related to communicable diseases

153

912

1.67

8.28

1.7

1.6

34.15

mmol/l

0.00

139

826

Non-allergic asthma (mode)

451

1.96

8.25

1.3

34.99

36.81

mmol/l

0.29

397

Migraine

210

1053

1.55

8.24

1.4

33.78

34.07

mmol/l

0.06

181

929

Malignant neoplasm of tongue

4.09

8.11

1.1

29.75

35.03

mmol/l

0.53

Malignant neoplasm of oral cavity

3.27

8.09

1.2

28.21

33.07

mmol/l

0.69

Other and unspecified effects of external causes

127

732

1.74

8.07

1.8

1.4

33.19

34.90

mmol/l

0.34

107

654

Faecal incontinence

273

2.25

8.07

1.5

1.1

31.19

34.93

mmol/l

0.83

230

Endovascular or surgical operations to intracerebral aneurysms

158

2.69

8.07

1.3

1.1

29.78

34.00

mmol/l

0.69

140

Soft tissue disorders related to use, overuse and pressure

144

860

1.68

8.05

1.2

33.40

33.67

mmol/l

0.05

120

759

Other viral hepatitis

114

3.01

8.04

1.7

1.2

39.28

36.44

mmol/l

0.20

106

Rheumatoid arthritis

168

921

1.62

8.00

1.2

32.57

33.53

mmol/l

0.24

137

800

Purpura and other haemorrhagic conditions

393

2.02

7.96

1.9

1.3

35.07

35.83

mmol/l

0.09

343

Benign neoplasm of other and ill-defined parts of digestive system

103

561

1.85

7.95

1.3

1.1

32.70

34.77

mmol/l

0.41

482

Prurigo nodularis

3.76

7.94

1.1

25.05

36.54

mmol/l

1.87

Drug-induced neutropenia

183

2.54

7.91

1.1

36.16

33.90

mmol/l

0.31

163

Migraine without aura

360

2.06

7.90

1.4

1.5

36.59

34.27

mmol/l

0.33

330

Malignant neoplasm of tongue, including Hilmo

3.64

7.88

1.1

1.2

30.84

34.03

mmol/l

0.32

Disorders of continuity of bone

238

2.33

7.87

1.5

1.2

35.89

36.48

mmol/l

0.06

212

Cervical disc disorders

171

1073

1.60

7.87

1.3

1.1

33.25

34.64

mmol/l

0.34

146

944

Insomnia

410

2099

1.36

7.86

1.2

31.56

33.85

mmol/l

1.34

359

1842

Other arthritis (FG)

151

920

1.65

7.83

1.2

34.95

35.01

mmol/l

0.01

127

805

241

1464

1.49

7.82

1.1

37.18

33.95

mmol/l

1.29

205

1245

Diseases of the musculoskeletal system and connective tissue

232

763

1.53

7.76

1.3

1.6

35.31

35.22

mmol/l

0.02

214

697

Enlarged lymph nodes

317

2.12

7.72

1.4

1.3

32.14

35.46

mmol/l

0.62

283

Other symptoms and signs involving general sensations and perceptions

117

2.94

7.72

1.2

1.3

33.43

36.44

mmol/l

0.27

103

Polyarthrosis

124

647

1.73

7.65

1.2

1.1

35.21

33.99

mmol/l

0.23

105

556

Pruritus

313

2.12

7.58

1.1

1.3

27.80

35.04

mmol/l

2.18

278

Benign neoplasm: Colon, unspecified

140

846

1.66

7.53

1.3

1.1

32.50

34.71

mmol/l

0.58

124

721

Monoamine oxidase A inhibitors

262

2.23

7.52

1.1

31.13

35.32

mmol/l

0.82

233

Obesity and other hyperalimentation

278

1830

1.43

7.50

1.1

1.2

32.14

33.86

mmol/l

0.68

238

1612

Other specified/unspecified arthritis

135

809

1.67

7.49

1.2

35.33

35.04

mmol/l

0.05

113

708

Acute upper respiratory infections

496

2260

1.32

7.47

1.3

1.2

32.94

34.13

mmol/l

0.56

428

1980

Misadventures to patients during surgical and medical care

396

1.98

7.46

1.4

1.2

35.47

34.86

mmol/l

0.08

347

Malignant neoplasm of oral cavity, including Hilmo

114

2.93

7.44

1.3

1.2

28.07

32.88

mmol/l

0.75

100

Benign neoplasm: Colon

284

1879

1.42

7.40

1.3

1.1

33.33

34.44

mmol/l

0.34

253

1613

226

2.32

7.40

1.2

1.1

31.66

36.87

mmol/l

1.07

195

Other viral diseases, including avohilmo

159

986

1.60

7.38

1.9

1.6

34.33

34.71

mmol/l

0.06

148

884

Mixed and other personality disorders

131

2.77

7.37

1.2

1.1

30.07

39.13

mmol/l

1.40

122

Irritable bowel syndrome

121

708

1.71

7.34

1.4

1.2

32.23

34.48

mmol/l

0.51

106

612

Actinic keratosis

226

1390

1.48

7.34

1.1

37.54

33.92

mmol/l

1.43

194

1176

Pacemaker

207

1279

1.51

7.32

1.2

1.1

35.18

35.40

mmol/l

0.05

187

1081

Gout

150

794

1.63

7.28

1.2

1.1

33.51

34.51

mmol/l

0.23

135

684

Malignant neoplasm of head and neck, including Hilmo

279

2.17

7.26

1.3

1.2

29.57

34.03

mmol/l

0.97

242

Trochanteric bursitis

435

1.92

7.25

1.3

1.2

33.71

34.29

mmol/l

0.08

376

Special screening examination for other diseases and disorders

253

2.22

7.25

1.1

1.2

31.66

36.40

mmol/l

0.96

225

Obesity

275

1822

1.42

7.24

1.1

1.2

32.07

33.89

mmol/l

0.74

235

1605

Pain in joint

242

1008

1.48

7.24

1.5

1.3

33.54

35.65

mmol/l

0.75

207

902

Benign neoplasm: Stomach

293

2.13

7.22

1.2

1.1

32.36

34.88

mmol/l

0.34

253

Ulcerative colitis

112

645

1.74

7.20

1.6

1.2

32.55

34.68

mmol/l

0.43

567

Ventral hernia

125

743

1.69

7.18

1.6

1.1

33.53

34.74

mmol/l

0.25

111

634

Lumbar disc prolapse

281

1464

1.42

7.17

1.3

1.2

32.91

34.58

mmol/l

0.68

245

1299

Injuries to the knee and lower leg

555

2324

1.29

7.17

1.4

1.3

32.46

34.29

mmol/l

1.09

475

2049

Obesity due to excess calories

200

1330

1.51

7.14

1.1

1.3

30.92

34.44

mmol/l

1.61

170

1176

Other disorders of kidney and ureter

396

1.96

7.12

1.3

1.2

27.33

34.56

mmol/l

2.28

344

Alzheimer disease, excluding more controls

316

1.89

7.11

1.1

35.16

38.06

mmol/l

0.53

269

Viral hepatitis, including avohilmo

151

2.60

7.11

1.6

1.2

38.29

37.46

mmol/l

0.06

141

Alzheimer’s disease (Late onset), excluding more controls

277

1.96

7.08

1.1

33.39

38.21

mmol/l

1.04

234

Other viral diseases, not elsewhere classified, including avohilmo

121

711

1.70

7.07

2.1

1.6

35.48

34.82

mmol/l

0.10

114

635

Excessive attrition of teeth

262

1820

1.43

7.07

1.3

32.27

34.31

mmol/l

0.76

233

1610

Recurrent aphthous stomatitis , including avohilmo

425

1.92

7.06

1.5

1.2

33.19

35.31

mmol/l

0.36

378

Sequelae of injuries, of poisoning and of other consequences of external causes

112

649

1.73

7.06

1.3

1.2

33.57

35.39

mmol/l

0.27

578

Rheumatism, unspecified

363

1.99

7.05

1.2

29.20

33.91

mmol/l

1.28

315

Myocardial infarction, strict

233

1125

1.47

6.97

1.2

1.1

35.86

33.42

mmol/l

0.81

199

958

Hepatomegaly and splenomegaly, not elsewhere classified

7.76

6.96

1.1

1.4

30.46

35.85

mmol/l

0.41

Skin changes due to chronic exposure to nonionizing radiation

229

1421

1.46

6.96

1.1

37.47

33.85

mmol/l

1.47

197

1204

Stomatitis and related lesions

102

579

1.77

6.92

1.5

1.3

33.59

35.22

mmol/l

0.31

508

Viral hepatitis

142

2.62

6.87

1.6

1.2

38.16

37.38

mmol/l

0.05

133

Other shoulder lesions

221

2.28

6.86

1.1

1.2

27.18

34.26

mmol/l

1.96

197

Vascular dementia

327

2.02

6.84

1.1

33.39

36.16

mmol/l

0.47

264

Thyrotoxicosis, other and/or unspecified

552

1.78

6.83

1.2

32.31

33.90

mmol/l

0.29

480

Disorders of refraction and accommodation

129

781

1.65

6.81

2.4

1.5

34.67

34.47

mmol/l

0.03

117

704

Adjustment and management of implanted device

101

575

1.77

6.80

2.3

1.1

36.41

35.71

mmol/l

0.11

480

Degeneration of macula and posterior pole

270

1475

1.42

6.75

1.1

1.2

32.37

34.96

mmol/l

1.17

222

1262

Conductive and sensorineural hearing loss

390

1939

1.34

6.71

1.3

1.2

32.34

34.56

mmol/l

1.35

334

1686

Superficial injury of abdomen, lower back and pelvis

420

1.89

6.64

1.5

1.2

32.41

35.43

mmol/l

0.46

373

Hydronephrosis

303

2.06

6.63

1.3

1.2

33.31

35.80

mmol/l

0.39

259

Degenerative diseases of the nervous system

220

1084

1.46

6.51

1.1

32.82

35.25

mmol/l

0.86

177

922

Assault by bodily force

152

2.52

6.51

1.1

1.2

33.39

37.17

mmol/l

0.27

146

Hernia of abdominal wall

217

1498

1.45

6.48

1.6

1.2

33.60

34.72

mmol/l

0.31

194

1296

Other and unspecified local infections of skin and subcutaneous tissue

273

2.10

6.45

2.2

1.3

39.93

34.32

mmol/l

0.67

246

Other and unspecified psoriasis

171

2.42

6.44

1.2

25.03

36.54

mmol/l

2.81

159

Thrombocytopenia, unspecified

202

2.30

6.44

2.3

1.3

31.40

34.95

mmol/l

0.47

180

Tubulo-interstitial nephritis, not specified as acute or chronic

165

2.44

6.43

1.5

1.1

25.82

35.13

mmol/l

2.79

148

Blepharochalasis

160

1042

1.54

6.38

1.1

1.2

33.60

34.25

mmol/l

0.16

136

882

Gout, FINNGEN

150

956

1.56

6.37

1.2

1.1

33.51

35.54

mmol/l

0.56

135

811

Other symptoms and signs involving the digestive system and abdomen

455

1.83

6.36

1.9

1.2

30.47

34.46

mmol/l

0.90

387

Extrapyramidal and movement disorders

201

1374

1.47

6.34

1.2

32.87

34.39

mmol/l

0.49

177

1168

Asthma and allergy, excluding more controls

213

2.23

6.33

1.7

1.5

28.08

35.51

mmol/l

1.85

197

Asthma and allergy

213

2.23

6.33

1.7

1.5

28.08

35.68

mmol/l

1.92

197

Viral infections characterized by skin and mucous membrane lesions

206

1415

1.46

6.30

1.4

1.3

33.16

34.78

mmol/l

0.46

189

1227

Other disorders of eyelid

236

1568

1.42

6.29

1.1

1.2

34.14

34.03

mmol/l

0.03

207

1341

Myeloproliferative diseases

230

2.19

6.28

1.1

34.44

34.14

mmol/l

0.03

201

Venous thromboembolism

270

1879

1.39

6.21

1.2

33.53

34.81

mmol/l

0.37

235

1616

Acute sinusitis

215

1358

1.44

6.13

1.4

1.2

33.53

34.12

mmol/l

0.14

185

1198

Convalescence

116

2.70

6.09

1.1

32.15

32.95

mmol/l

0.05

103

Other congenital malformations of intestine

6.23

6.07

9.1

2.3

47.67

26.92

mmol/l

1.76

Other diseases of biliary tract

267

2.07

6.04

1.6

1.2

35.51

33.77

mmol/l

0.26

236

Fitting and adjustment of other devices

185

1103

1.48

6.03

1.1

31.94

35.04

mmol/l

1.34

162

935

Diabetic nephropathy

530

1.74

6.02

1.2

28.23

34.06

mmol/l

2.44

450

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

418

2510

1.30

6.01

1.3

33.63

33.89

mmol/l

0.08

368

2205

Seronegative rheumatoid arthritis

316

1.97

5.95

1.2

1.1

31.37

33.70

mmol/l

0.43

271

Malignant neoplasm of respiratory system and intrathoracic organs

113

568

1.66

5.94

1.1

34.30

33.98

mmol/l

0.06

104

473

Fissure and fistula of anal and rectal regions

105

629

1.67

5.94

1.5

1.1

34.84

35.30

mmol/l

0.06

549

Chronic sinusitis

188

1286

1.46

5.89

1.3

1.2

34.69

34.64

mmol/l

0.01

165

1127

Malignant neoplasm of tonsil and base of tongue, including Hilmo

3.33

5.89

1.3

1.1

27.37

34.55

mmol/l

0.77

182

1061

1.48

5.87

1.1

31.14

35.69

mmol/l

2.46

149

888

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

150

970

1.53

5.83

1.4

1.5

33.03

34.79

mmol/l

0.41

128

875

Disorders of sclera, cornea, iris and ciliary body

246

1773

1.39

5.82

1.3

1.2

33.21

34.21

mmol/l

0.30

221

1534

Other necrotizing vasculopathies

205

2.21

5.82

1.2

33.94

36.22

mmol/l

0.27

180

Diseases of peritoneum

278

2.03

5.80

1.6

1.2

32.41

35.26

mmol/l

0.39

246

Certain disorders involving the immune mechanism

558

1.71

5.80

1.5

1.3

28.64

35.60

mmol/l

2.87

492

Other (seronegative) rheumatoid arthritis, wide

102

611

1.68

5.79

1.2

1.1

31.93

34.36

mmol/l

0.61

523

Sicca syndrome [Sjögren]

245

2.10

5.77

1.2

1.1

30.89

34.12

mmol/l

0.56

214

Chronic viral hepatitis

2.93

5.73

1.7

1.1

40.40

36.88

mmol/l

0.19

Papulosquamous disorders

181

1239

1.46

5.71

1.2

33.77

34.64

mmol/l

0.20

159

1080

Sensorineural hearing loss

369

1878

1.31

5.64

1.4

1.2

31.99

34.46

mmol/l

1.61

318

1630

Statin medication

266

1083

1.38

5.63

1.2

1.3

34.01

34.40

mmol/l

0.10

239

959

Parkinson's disease, excluding more controls

289

1.95

5.62

1.1

34.16

37.97

mmol/l

0.74

249

Other necrotizing vasculopathies (FG)

170

2.31

5.61

1.2

34.05

34.71

mmol/l

0.06

147

Hypoplasia of dental enamel, prenatal

6.47

5.59

2.5

3.4

25.07

33.31

mmol/l

0.53

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

225

1551

1.40

5.56

1.3

1.2

33.20

34.70

mmol/l

0.49

194

1368

Pemphigoid

3.03

5.55

1.1

1.2

36.21

34.26

mmol/l

0.12

Hypoplasia of dental enamel, prenatal , including avohilmo

5.55

5.54

2.9

3.2

27.33

35.55

mmol/l

0.53

Amputation of toe

203

2.18

5.53

1.3

1.1

28.81

35.61

mmol/l

1.60

180

Other local infections of skin and subcutaneous tissue

297

1.96

5.53

2.2

1.2

40.59

34.66

mmol/l

0.74

267

Myeloproliferative diseases (CML excluded)

210

2.16

5.50

1.0

1.1

33.31

34.41

mmol/l

0.12

185

Other congenital malformations of intestine, including avohilmo

5.00

5.48

8.6

2.0

45.94

30.91

mmol/l

1.17

Dementia

241

1186

1.39

5.47

1.1

32.29

35.18

mmol/l

1.17

201

1008

Disease of hard tissues of teeth, NOS

243

909

1.40

5.46

1.1

35.68

35.00

mmol/l

0.18

216

812

Diabetic retinopathy, strict definition

475

1.71

5.46

1.1

1.2

27.24

34.12

mmol/l

3.32

412

Diabetic retinopathy, excluding more controls

131

463

1.59

5.45

1.1

1.2

29.77

34.01

mmol/l

1.68

114

396

Fracture of foot, except ankle

110

683

1.62

5.44

1.3

1.2

30.77

34.63

mmol/l

1.08

606

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

123

641

1.58

5.44

1.1

34.62

33.72

mmol/l

0.18

113

537

Other/unspecified rheumatoid arthritis

377

1.84

5.42

1.1

1.2

30.49

34.58

mmol/l

1.09

321

Exposure to other specified factors

355

2341

1.30

5.40

1.3

1.4

32.43

34.08

mmol/l

0.68

306

2070

Chronic rhinitis, nasopharyngitis and pharyngitis

144

953

1.51

5.39

1.4

1.3

32.04

35.22

mmol/l

0.98

125

848

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

472

1.73

5.38

1.7

1.8

34.19

35.85

mmol/l

0.25

431

Dementia, including avohilmo

259

1291

1.37

5.37

1.1

32.39

35.03

mmol/l

1.11

217

1102

IBD patients in KELA-register

548

1.68

5.36

1.7

1.2

37.97

34.64

mmol/l

0.51

487

Periapical abscess

199

1406

1.42

5.33

1.2

30.25

34.76

mmol/l

2.20

175

1245

Congenital malformations of the circulatory system

424

1.77

5.33

1.6

1.8

35.61

35.65

mmol/l

0.00

392

Polyglandular dysfunction, other/unspecified

+∞

5.32

1.2

0.0

37.80

—

mmol/l

—

Unspecified dementia

346

1.82

5.27

1.1

32.26

35.22

mmol/l

0.54

281

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

430

2135

1.27

5.26

1.2

34.65

34.16

mmol/l

0.16

382

1853

Hyperplasia of prostate

153

569

1.52

5.26

1.2

36.33

36.53

mmol/l

0.03

135

510

Abnormal involuntary movements

388

1.81

5.26

1.9

1.2

30.82

34.09

mmol/l

0.65

339

Alzheimer’s disease (Atypical or mixed), excluding more controls

181

2.07

5.26

1.0

1.1

32.00

38.55

mmol/l

1.38

156

Sleep apnoea

421

2082

1.28

5.21

1.3

1.2

32.88

33.88

mmol/l

0.41

364

1834

Primary_lymphoid and hematopoietic malignant neoplasms

128

833

1.54

5.21

1.3

1.2

34.97

mmol/l

0.00

119

713

Diabetic neuropathy

373

1.83

5.21

1.4

1.2

27.06

34.63

mmol/l

3.06

317

Zoster [herpes zoster]

101

622

1.63

5.20

1.4

1.1

35.35

34.43

mmol/l

0.15

527

Allergic asthma (mode), excluding more controls

422

1.76

5.20

1.5

1.3

30.62

36.46

mmol/l

1.31

378

Overexertion and strenuous or repetitive movements

236

2.05

5.14

1.8

1.1

38.87

36.61

mmol/l

0.22

215

Migraine without aura and triptan purchases

291

1.93

5.13

1.5

35.11

34.17

mmol/l

0.11

267

Progressive vascular leukoencephalopathy

146

2.36

5.10

1.3

1.1

35.60

35.46

mmol/l

0.01

127

Other infectious diseases

197

2.15

5.09

1.7

1.2

36.60

36.50

mmol/l

0.01

179

Pulmonary heart disease, diseases of pulmonary circulation

166

1146

1.45

5.07

1.2

32.36

35.39

mmol/l

0.87

147

975

Atypical facial pain

122

2.48

5.04

1.1

28.48

34.75

mmol/l

0.65

114

Right hemicolectomy

166

2.25

5.01

1.5

1.1

38.27

36.42

mmol/l

0.18

147

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

121

760

1.55

5.01

1.1

1.2

37.67

33.67

mmol/l

1.21

106

637

Seropositive rheumatoid arthritis

121

781

1.55

5.00

1.2

1.1

32.30

34.63

mmol/l

0.61

678

Fibroblastic disorders

109

691

1.58

4.99

1.2

1.1

37.04

34.92

mmol/l

0.46

598

Migraine with aura and triptan purchases

301

1.90

4.99

1.4

28.91

34.15

mmol/l

0.96

272

Diseases of salivary glands

149

1011

1.48

4.99

1.3

1.2

32.86

34.64

mmol/l

0.41

131

880

Unspecified privation

295

1.91

4.95

1.5

1.2

25.59

35.17

mmol/l

3.15

262

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

507

1.67

4.95

1.6

1.8

33.88

36.13

mmol/l

0.37

460

Zoster [herpes zoster], including avohilmo

255

1834

1.34

4.94

1.2

35.85

33.84

mmol/l

0.67

221

1582

Pyogenic arthritis

167

2.23

4.94

1.7

1.2

34.86

35.33

mmol/l

0.03

145

Fibromyalgia

193

2.13

4.93

1.3

1.2

31.03

33.11

mmol/l

0.26

167

Other infectious diseases, including avohilmo

247

2.00

4.93

1.6

1.2

37.13

35.12

mmol/l

0.23

223

Disorders of tooth development and eruption

325

1.78

4.92

1.5

1.4

33.71

33.15

mmol/l

0.08

288

Nummular dermatitis

227

2.04

4.90

1.1

1.2

27.26

36.76

mmol/l

2.13

203

Lesion of ulnar nerve

361

1.81

4.88

1.2

31.53

34.70

mmol/l

0.64

325

Unspecified urinary incontinence

262

1.96

4.87

1.1

1.2

28.80

33.74

mmol/l

1.49

232

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

364

1.75

4.84

1.9

2.4

36.20

34.60

mmol/l

0.20

347

Malignant neoplasm of eye, brain and central nervous system

107

2.55

4.80

1.2

1.3

30.28

34.89

mmol/l

0.76

Benign neoplasm of mouth and pharynx

306

1.87

4.78

1.2

35.20

34.65

mmol/l

0.05

269

Diplopia

401

1.75

4.75

1.2

32.45

35.57

mmol/l

0.58

356

Malignant neoplasm of bronchus and lung

510

1.61

4.74

1.2

1.1

34.52

34.27

mmol/l

0.04

424

Bell's palsy

314

1.86

4.74

1.2

35.82

35.10

mmol/l

0.09

284

Disorders of optic nerve and visual pathways

237

1.99

4.73

1.6

1.3

39.40

35.57

mmol/l

0.42

217

Hyperparathyroidism

101

631

1.59

4.72

1.1

30.55

34.27

mmol/l

1.01

524

Other diseases of upper respiratory tract

504

2123

1.24

4.71

1.3

33.00

34.53

mmol/l

0.77

428

1867

Digestive system disorders of fetus and newborn

11.68

4.71

7.4

3.0

41.00

28.75

mmol/l

—

Other disorders of eye and adnexa

388

1.76

4.68

1.4

1.2

35.99

35.68

mmol/l

0.04

344

Parkinson's disease, strict definition, excluding more controls

273

1.89

4.68

1.1

34.99

38.03

mmol/l

0.50

235

Speech therapy

128

855

1.50

4.66

1.8

1.2

33.83

34.67

mmol/l

0.16

117

738

Thyroiditis, ILD-related definition

302

1.86

4.64

1.1

1.2

31.50

35.20

mmol/l

0.65

268

Malignant neoplasm of bronchus and lung, including Hilmo

108

577

1.57

4.63

1.1

34.87

34.20

mmol/l

0.12

481

Cardiodefibrillation

176

1248

1.41

4.62

1.1

35.67

34.66

mmol/l

0.23

155

1062

Injury of other and unspecified intrathoracic organs

153

2.24

4.59

1.4

1.1

38.57

36.91

mmol/l

0.12

139

Open wound of ankle and foot

289

1.88

4.58

1.3

1.2

33.94

35.91

mmol/l

0.28

262

Redundant prepuce, phimosis and paraphimosis

488

1.66

4.56

1.4

1.2

31.66

35.30

mmol/l

0.91

435

Injuries to the neck

606

1.59

4.52

1.2

31.46

35.36

mmol/l

0.97

535

Inflammatory bowel disease, strict (require KELA)

575

1.60

4.51

1.7

1.2

37.97

35.11

mmol/l

0.42

510

Infections with a predominantly sexual mode of transmission

628

1.58

4.51

1.3

32.01

34.27

mmol/l

0.47

559

Short stature, not elsewhere classified

2.59

4.50

8.2

3.4

27.97

39.52

mmol/l

1.35

Ulcerative colitis, NAS

342

1.79

4.47

1.6

1.2

32.73

35.16

mmol/l

0.33

304

Sleep apnoea, including avohilmo

435

2114

1.25

4.44

1.3

1.2

33.47

33.80

mmol/l

0.11

375

1858

Congenital absence, atresia and stenosis of small intestine

13.49

4.43

8.6

2.7

46.29

22.50

mmol/l

—

Undefined dementia

384

1.71

4.42

1.1

32.18

34.69

mmol/l

0.45

307

Abnormal findings on diagnostic imaging of other body structures

433

1.69

4.41

1.2

1.1

35.05

34.28

mmol/l

0.11

379

Other extrapyramidal and movement disorders in other diseases

122

818

1.50

4.39

1.2

31.70

34.66

mmol/l

0.85

106

707

Allergic asthma (mode)

445

1.67

4.37

1.5

1.3

30.62

36.02

mmol/l

1.17

400

Vasomotor and allergic rhinitis

150

1024

1.43

4.35

1.5

1.6

32.54

35.15

mmol/l

0.69

125

920

Palmar fascial fibromatosis [Dupuytren]

435

1.68

4.34

1.2

35.74

35.53

mmol/l

0.03

373

Thyrotoxicosis

117

781

1.50

4.31

1.2

31.34

33.69

mmol/l

0.59

101

664

Other sleep disorders

274

1.87

4.30

1.2

37.09

34.96

mmol/l

0.26

241

Vascular dementia (subcortical)

126

2.33

4.28

1.2

1.1

30.58

34.68

mmol/l

0.52

109

Psoriasis

125

847

1.48

4.28

1.3

1.2

31.19

35.22

mmol/l

1.33

107

743

Other disorders of skin and subcutaneous tissue, not elsewhere classified

437

1.68

4.27

1.8

1.2

32.16

35.39

mmol/l

0.60

380

Postprocedural musculoskeletal disorders, not elsewhere classified

205

2.01

4.27

1.4

1.1

34.43

34.42

mmol/l

0.00

184

Unspecified acute lower respiratory infection

416

1.69

4.21

1.4

1.3

33.80

35.54

mmol/l

0.25

367

Acute peritonitis

173

2.10

4.17

2.0

1.2

34.67

35.34

mmol/l

0.05

158

Gout, unspecified

101

659

1.54

4.16

1.3

1.1

34.22

35.49

mmol/l

0.25

570

Rheumatoid arthritis, including avohilmo

178

1296

1.38

4.12

1.2

32.65

34.14

mmol/l

0.44

145

1113

Contact with and exposure to communicable diseases

102

665

1.53

4.11

1.5

1.6

35.55

34.23

mmol/l

0.22

606

Disorders of conjunctiva

369

2288

1.25

4.10

1.2

1.3

32.06

33.82

mmol/l

0.90

321

2012

Hallux valgus (acquired)

157

794

1.42

4.10

1.1

1.2

29.65

33.73

mmol/l

1.83

128

692

Valvular operations

382

1.71

4.08

1.3

37.94

36.01

mmol/l

0.26

328

Burns and corrosions

360

1.73

4.07

1.5

1.3

33.52

36.35

mmol/l

0.41

329

DVT of lower extremities and pulmonary embolism

203

1505

1.35

4.06

1.2

33.12

34.88

mmol/l

0.50

181

1283

Scar conditions and fibrosis of skin

2.47

4.05

1.1

40.11

35.75

mmol/l

0.36

Failure and rejection of transplanted organs and tissues

4.27

4.03

1.7

1.5

20.62

32.08

mmol/l

1.15

Glaucoma

281

1856

1.29

4.03

1.1

1.2

31.50

34.55

mmol/l

1.81

247

1595

Excessive earwax

300

2134

1.28

4.03

1.3

1.2

32.56

34.22

mmol/l

0.72

267

1855

Diseases of male genital organs

201

741

1.37

4.02

1.3

1.4

37.02

35.93

mmol/l

0.23

181

674

Delayed milestone in childhood

2.41

4.01

4.7

3.4

31.38

35.15

mmol/l

0.32

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

143

2.19

3.99

1.0

1.2

31.71

34.37

mmol/l

0.30

123

Coronary artery bypass grafting

124

626

1.47

3.99

1.1

29.81

34.62

mmol/l

1.92

105

528

Other specified and unspecified retinal disorders

2.50

3.97

1.3

1.1

31.09

35.53

mmol/l

0.50

L01XE Protein kinase inhibitors

150

2.15

3.97

1.3

1.1

36.11

34.88

mmol/l

0.10

134

Carcinoma in situ of skin of other and unspecified parts of face

297

1.80

3.95

1.1

35.17

34.51

mmol/l

0.07

247

Polycystic ovarian syndrome, consortium definition

301

1349

1.28

3.93

1.5

1.2

30.67

33.07

mmol/l

1.17

254

1175

Open wound of forearm

247

1.87

3.92

1.3

1.2

35.57

36.32

mmol/l

0.07

220

Malignant neoplasm of digestive organs, including Hilmo

206

1131

1.34

3.90

1.3

1.2

35.38

33.26

mmol/l

0.67

188

952

Flat foot [pes planus] (acquired)

248

1.86

3.87

1.1

1.2

30.36

34.65

mmol/l

0.75

218

Car occupant injured in other and unspecified transport accidents

465

1.62

3.86

1.5

1.2

35.12

35.30

mmol/l

0.02

414

Olecranon bursitis

145

2.15

3.86

1.1

1.2

30.66

34.83

mmol/l

0.65

126

Gout, idiopatic and unspecified

119

817

1.46

3.86

1.2

1.1

32.96

35.25

mmol/l

0.60

107

700

Spondylolisthesis/Spondylolysis

505

1.59

3.83

1.0

1.2

30.05

35.85

mmol/l

1.57

446

Obesity, other/unspecified

125

868

1.44

3.82

1.1

1.2

33.72

34.61

mmol/l

0.16

108

773

Arthropathies

367

1486

1.25

3.81

1.4

34.34

34.50

mmol/l

0.04

330

1323

Basal cell carcinoma, including Hilmo

225

1156

1.32

3.78

1.1

1.2

35.68

33.07

mmol/l

0.92

193

970

Keratitis

154

1112

1.39

3.78

1.3

1.2

31.07

34.45

mmol/l

1.25

138

969

Heartburn

265

1.82

3.76

1.2

30.95

35.62

mmol/l

0.81

229

Irregular menses

170

933

1.37

3.72

1.7

1.3

31.04

32.93

mmol/l

0.52

151

821

Conduction disorders

131

735

1.43

3.71

1.2

35.36

34.64

mmol/l

0.15

112

629

Colonic or urogenital fistula

114

783

1.46

3.71

1.5

1.2

34.73

34.64

mmol/l

0.01

689

Disorders of skin appendages

195

1461

1.33

3.66

1.2

1.4

29.96

34.91

mmol/l

2.66

162

1298

Biological medication for rheuma

419

1.63

3.62

1.7

1.3

34.74

35.61

mmol/l

0.09

380

Conjunctivitis

326

2106

1.25

3.62

1.3

32.25

33.59

mmol/l

0.58

286

1861

Other arthrosis

233

1199

1.30

3.60

1.2

34.27

34.30

mmol/l

0.01

199

1052

Pulmonary heart disease

145

1046

1.39

3.60

1.3

1.1

31.80

35.15

mmol/l

0.96

129

886

Bronchiectasis

233

1.86

3.60

1.4

1.2

31.66

33.09

mmol/l

0.15

209

130

858

1.42

3.60

1.1

30.54

35.79

mmol/l

2.41

108

713

Diabetic retinopathy

175

799

1.36

3.59

1.1

1.2

29.48

33.60

mmol/l

2.12

152

693

Injuries to unspecified part of trunk, limb or body region

284

1.77

3.59

1.5

1.3

30.75

35.66

mmol/l

0.68

253

Glaucoma-related operations

191

1.95

3.58

1.1

1.2

28.07

35.25

mmol/l

2.13

167

Acute suppurative otitis media

538

1.53

3.55

2.3

1.8

29.66

35.84

mmol/l

1.89

495

Other hammer toe(s) (acquired)

547

1.52

3.54

1.1

1.2

31.38

33.73

mmol/l

0.61

471

Seropositive rheumatoid arthritis, strict definition

445

1.60

3.54

1.2

1.1

32.33

34.20

mmol/l

0.30

387

Infective dermatitis

315

1.72

3.54

1.0

1.2

31.52

36.54

mmol/l

1.19

277

Use of pramipexole

107

734

1.46

3.53

1.1

33.17

34.13

mmol/l

0.20

629

Coxarthrosis [arthrosis of hip](FG)

246

1315

1.29

3.51

1.1

34.17

34.48

mmol/l

0.07

207

1148

Use of biperiden

118

2.22

3.51

1.2

1.1

27.92

36.71

mmol/l

1.43

107

Pulmonary embolism

145

1051

1.38

3.51

1.3

1.2

31.80

35.14

mmol/l

0.96

129

892

Ulcerative proctitis

118

2.21

3.51

1.3

1.2

26.28

36.81

mmol/l

2.95

110

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

228

1185

1.30

3.47

1.1

1.2

35.31

32.91

mmol/l

0.81

194

997

Diseases of the ear and mastoid process

479

2000

1.20

3.44

1.2

1.3

33.34

34.40

mmol/l

0.50

426

1754

Malignant neoplasm of urinary organs

288

1.74

3.44

1.1

36.86

33.98

mmol/l

0.34

243

Ulcer of oesophagus

180

1.96

3.43

1.1

40.66

34.95

mmol/l

0.38

161

Anterior Iridocyclitis

576

1.52

3.42

1.2

36.43

35.42

mmol/l

0.14

504

AV-block

456

1.54

3.40

1.1

1.2

36.54

35.92

mmol/l

0.09

383

Diseases of inner ear

249

1874

1.27

3.39

1.2

32.80

34.13

mmol/l

0.47

212

1618

Basal cell carcinoma

216

1133

1.30

3.34

1.1

1.2

36.04

32.99

mmol/l

1.11

186

952

Atrophic disorders of skin

460

1.57

3.33

1.2

1.1

34.66

33.96

mmol/l

0.08

396

Congenital malformations of gallbladder, bile ducts and liver

3.72

3.32

1.7

1.9

22.69

32.58

mmol/l

1.02

Infections with a predominantly sexual mode of transmission, including avohilmo

122

792

1.41

3.32

1.3

31.73

33.91

mmol/l

0.53

111

708

Burns and corrosions of external body surface, specified by site

284

1.73

3.31

1.6

1.3

33.60

37.71

mmol/l

0.54

266

Disorders of vestibular function (Vertigo)

222

1684

1.29

3.29

1.1

1.2

32.54

34.10

mmol/l

0.53

186

1455

Diabetic maculopathy

376

1.61

3.29

1.1

1.2

28.25

34.03

mmol/l

1.91

324

Isolated growth hormone deficiency

3.46

3.27

6.5

2.3

29.09

36.56

mmol/l

0.49

Superficial injury of thorax

423

1.59

3.27

1.2

32.09

36.04

mmol/l

0.74

368

In situ neoplasms

183

1392

1.32

3.26

1.1

1.2

34.40

mmol/l

0.00

163

1184

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

591

1.49

3.26

1.1

35.11

33.32

mmol/l

0.42

500

Malignant neoplasm, without specification of site

2.35

3.25

1.0

1.2

31.10

34.42

mmol/l

0.27

Other malignant neoplasms of skin (=non-melanoma skin cancer)

219

1151

1.29

3.24

1.1

1.2

36.63

32.99

mmol/l

1.45

187

967

Iridocyclitis

674

1.46

3.22

1.2

36.78

34.66

mmol/l

0.37

584

Other and unspecified nerve root and plexus disorders, also in other diseases

560

1.50

3.22

1.2

29.90

35.05

mmol/l

1.40

499

Acute and subacute iridocyclitis

544

1.51

3.22

1.2

35.88

34.96

mmol/l

0.13

472

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

222

1661

1.28

3.21

1.3

34.29

33.24

mmol/l

0.31

195

1461

Other noninflammatory disorders of vulva and perineum

228

1.81

3.19

1.6

1.1

25.66

33.57

mmol/l

2.83

200

Bullous disorders

171

1.94

3.19

1.2

35.81

35.77

mmol/l

0.00

155

Other respiratory diseases principally affecting the interstitium

594

1.49

3.19

1.3

1.1

34.35

34.82

mmol/l

0.08

502

Allergic conjunctivitis

232

1757

1.27

3.17

1.3

33.86

33.07

mmol/l

0.23

201

1548

Superficial injury of lower leg

110

776

1.42

3.16

1.5

1.3

34.64

35.15

mmol/l

0.07

676

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

251

1.76

3.16

1.2

1.1

31.24

35.21

mmol/l

0.67

221

Covid-19 suspected case

515

1.52

3.14

1.5

1.2

33.82

34.19

mmol/l

0.04

459

Polycythaemia vera

2.27

3.13

1.0

1.2

32.88

33.30

mmol/l

0.03

Coeliac disease

312

1.67

3.12

1.4

1.2

30.02

36.03

mmol/l

1.28

280

Gout, strict definition

573

1.49

3.11

1.1

31.66

35.59

mmol/l

1.04

499

Other disorders of the musculoskeletal system and connective tissue

461

1.55

3.09

1.3

1.2

33.90

35.29

mmol/l

0.20

399

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

238

1.77

3.09

1.3

1.1

26.19

34.83

mmol/l

2.19

208

Voice disturbances

116

830

1.40

3.09

1.2

33.97

34.33

mmol/l

0.06

718

Pre-eclampsia or poor fetal growth

579

1.48

3.08

1.3

27.67

32.96

mmol/l

2.16

512

Arthrosis

292

1286

1.25

3.08

1.1

1.2

34.72

34.44

mmol/l

0.07

252

1131

Necrosis of pulp, including avohilmo

220

1708

1.27

3.07

1.5

1.2

33.02

34.03

mmol/l

0.27

191

1512

Visual field defects

231

1.78

3.07

1.7

1.2

34.01

35.69

mmol/l

0.17

202

Small fibre neuropathy

2.40

3.07

1.1

36.11

36.45

mmol/l

0.01

Injury of eye and orbit

329

1.65

3.06

2.0

1.2

36.41

36.34

mmol/l

0.01

293

Malignant neoplasm of bone and articular cartilage of limbs

6.04

3.05

2.9

1.3

40.71

34.67

mmol/l

—

Hereditary nephropathy, not elsewhere classified

10.43

3.01

1.2

1.0

30.30

26.20

mmol/l

—

Flatulence and related conditions

4.35

3.01

1.9

1.4

17.54

33.67

mmol/l

—

Embolic stroke

133

2.04

3.01

1.3

1.2

43.46

35.20

mmol/l

0.71

116

Other specific joint derangements/joint disorders

284

1427

1.24

2.99

1.5

1.3

33.01

34.42

mmol/l

0.49

243

1271

Seropositive rheumatoid arthritis, wide

121

878

1.38

2.98

1.2

32.30

34.23

mmol/l

0.48

754

Congenital absence, atresia and stenosis of large intestine

7.33

2.95

5.5

4.0

28.18

35.67

mmol/l

—

Malignant neoplasm of skin, including Hilmo

237

1261

1.26

2.90

1.1

35.17

32.88

mmol/l

0.79

202

1067

Congenital malformations of heart and great arteries

377

1.58

2.89

1.7

1.9

37.65

36.02

mmol/l

0.20

351

Other joint disorders

344

1477

1.22

2.89

1.5

1.4

32.91

34.45

mmol/l

0.66

301

1314

Routine general health check-up of defined subpopulation

3.73

2.88

1.1

1.3

33.40

39.85

mmol/l

—

Status post-ami

118

648

1.38

2.85

1.1

34.03

34.67

mmol/l

0.12

105

548

Subjective visual disturbances

109

784

1.39

2.85

1.2

33.90

35.18

mmol/l

0.22

686

Superficial injury of forearm

237

1.74

2.84

1.9

1.2

32.13

35.91

mmol/l

0.30

217

Malignant neoplasm of skin

227

1218

1.26

2.84

1.1

1.2

35.83

32.91

mmol/l

1.08

193

1027

Mucosal proctocolitis

291

1.65

2.80

1.7

1.2

36.60

34.92

mmol/l

0.17

266

Other bursopathies

361

1.58

2.80

1.1

1.2

35.73

33.22

mmol/l

0.38

308

Acute lymphocytic leukaemia, helper endpoint

4.01

2.80

2.6

3.9

23.44

34.65

mmol/l

—

Acute lymphocytic leukaemia

4.01

2.80

2.6

3.9

23.44

34.65

mmol/l

—

Acute lymphocytic leukaemia, including Hilmo

4.01

2.80

2.6

3.9

23.44

34.65

mmol/l

—

Osteosarcoma

8.75

2.78

3.6

1.7

45.20

30.50

mmol/l

—

Localized swelling, mass and lump of skin and subcutaneous tissue

138

1035

1.34

2.78

1.4

1.2

30.22

34.54

mmol/l

1.96

124

903

Disorders of synovium and tendon

219

1476

1.26

2.78

1.2

34.18

34.16

mmol/l

0.00

187

1307

Pollen allergy

427

1.53

2.77

1.5

2.0

32.24

35.64

mmol/l

0.52

400

L04AC Interleukin inhibitors

138

1.97

2.75

1.9

1.3

38.32

37.24

mmol/l

0.06

129

Restless leg syndrome

427

1.53

2.73

1.2

31.82

34.67

mmol/l

0.53

370

Squamous cell neoplasms and carcinomas of the skin

340

1.59

2.72

1.1

40.14

32.59

mmol/l

1.23

279

HSIL lesion of the cervix uteri, vagina or vulva

348

1.58

2.71

1.5

1.3

33.45

33.14

mmol/l

0.03

309

Inguinal hernia

239

1274

1.25

2.71

1.2

35.89

34.73

mmol/l

0.35

209

1118

Rash and other nonspecific skin eruption

271

1.67

2.71

1.6

1.3

34.63

34.19

mmol/l

0.05

238

Methotrexate

373

1.56

2.68

1.6

1.2

32.88

34.21

mmol/l

0.18

324

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

105

760

1.38

2.66

1.2

1.3

38.09

34.80

mmol/l

0.66

685

Dementia in other diseases classified elsewhere

140

1.94

2.65

1.2

28.17

34.86

mmol/l

1.24

122

Malignant neoplasm of urinary organs, including Hilmo

335

1.59

2.64

1.1

35.56

33.69

mmol/l

0.22

285

Disorders of muscles

250

1.69

2.64

1.1

1.2

26.27

34.60

mmol/l

2.22

218

Strabismus

108

785

1.37

2.63

1.6

1.4

33.65

34.62

mmol/l

0.16

701

Other/unspecified seropositive rheumatoid arthritis

118

873

1.35

2.63

1.2

32.50

34.31

mmol/l

0.42

750

Dislocation, sprain and strain of joints and ligaments of thorax

2.27

2.61

1.2

1.1

25.23

36.13

mmol/l

2.06

Cervicobrachial syndrome

554

1.45

2.61

1.5

1.1

31.25

35.29

mmol/l

1.05

491

Other ulcerative colitis

120

2.01

2.60

2.0

1.2

26.99

35.79

mmol/l

1.64

115

Other peripheral vertigo

282

1.64

2.60

1.2

1.1

33.54

35.38

mmol/l

0.25

245

Urethral stricture

127

1.98

2.60

1.1

35.09

37.39

mmol/l

0.13

112

ILD, hospital admissions

498

1.47

2.58

1.3

1.1

34.30

34.56

mmol/l

0.04

427

Herpesviral [herpes simplex] infections

306

1.61

2.58

1.5

1.2

29.50

34.40

mmol/l

0.81

269

Other crystal arthropathies

2.63

2.54

1.2

37.38

32.50

mmol/l

—

Glaucoma suspect

173

1357

1.28

2.53

1.2

31.18

34.78

mmol/l

1.72

153

1165

Coxarthrosis

220

1138

1.25

2.53

1.1

1.2

34.46

34.40

mmol/l

0.01

185

995

Salpingitis and oophoritis

484

1.47

2.53

1.5

1.2

31.94

32.89

mmol/l

0.14

412

Other disorders of the genitourinary system

420

1.51

2.50

1.6

1.1

35.32

33.42

mmol/l

0.28

358

D07AA Corticosteroids, weak (group I)

411

1.51

2.50

1.2

1.7

30.02

35.12

mmol/l

1.17

379

Myocardial infarction, unclassifiable

104

678

1.37

2.50

1.2

1.1

33.90

35.49

mmol/l

0.36

562

Malignant neoplasm, without specification of site, including Hilmo

136

1.92

2.50

1.0

1.1

30.69

34.60

mmol/l

0.39

114

Nonsuppurative otitis media

491

1.43

2.48

2.3

1.8

32.19

35.78

mmol/l

0.76

447

Dermatophytosis, including avohilmo

259

2088

1.22

2.47

1.2

32.92

34.39

mmol/l

0.54

223

1829

Sulfasalazine

104

763

1.37

2.46

1.2

32.90

34.87

mmol/l

0.42

669

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

210

1.72

2.46

1.7

1.2

36.48

34.89

mmol/l

0.18

190

malignant neoplasm of female genital organs, including Hilmo

606

1.40

2.45

1.2

1.1

31.37

32.80

mmol/l

0.26

499

Other interstitial pulmonary diseases

512

1.45

2.45

1.3

1.1

34.20

34.61

mmol/l

0.06

435

Use of antiglaucoma preparations and miotics

256

1.65

2.45

1.1

31.10

34.82

mmol/l

0.97

209

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

2.26

2.45

1.2

1.1

26.58

32.69

mmol/l

0.46

Interstitial lung disease endpoints

513

1.45

2.43

1.3

1.1

34.20

34.56

mmol/l

0.05

436

Interstitial lung disease

513

1.45

2.43

1.3

1.1

34.20

34.56

mmol/l

0.05

436

Acetic acid derivatives and related substances

120

460

1.35

2.39

1.2

34.45

33.55

mmol/l

0.16

104

411

Enthesopathies of lower limb, excluding foot

573

1.42

2.39

1.1

1.2

30.91

35.49

mmol/l

1.29

510

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

115

863

1.34

2.37

1.2

32.35

34.13

mmol/l

0.41

742

Pain and other conditions associated with female genital organs and menstrual cycle

374

1.48

2.37

1.3

31.10

33.40

mmol/l

0.37

329

Allergic rhinitis

107

784

1.35

2.36

1.5

1.7

30.86

35.05

mmol/l

1.08

713

Other/unspecified synovitis and tenosynovitis

282

1.60

2.36

1.2

31.92

33.77

mmol/l

0.25

242

Psoriasis vulgaris

542

1.42

2.34

1.3

1.2

33.33

35.13

mmol/l

0.30

479

Other disorders of cornea

283

1.60

2.33

1.4

1.2

34.04

34.74

mmol/l

0.08

247

Retinal vascular disorders

419

1.49

2.33

1.3

1.1

35.67

35.22

mmol/l

0.06

351

Other and unspecified visual disturbances

292

1.58

2.30

1.2

32.09

35.32

mmol/l

0.60

257

Adverse effects, not elsewhere classified

536

1.42

2.29

2.2

1.4

34.77

34.21

mmol/l

0.07

477

Cholelithiasis, broad definition with cholecystitis

359

2032

1.18

2.29

1.4

1.1

34.63

34.21

mmol/l

0.13

304

1767

malignant neoplasm of female genital organs

557

1.41

2.29

1.3

1.1

31.76

32.70

mmol/l

0.15

457

Disorders in reading

2.78

2.28

1.8

2.4

37.09

39.46

mmol/l

0.10

Memory loss

285

1.59

2.27

1.1

32.20

34.46

mmol/l

0.34

239

Other benign neoplasms of skin

162

1282

1.27

2.26

1.2

33.40

34.60

mmol/l

0.27

139

1100

Retinal vascular occlusion

414

1.48

2.26

1.3

1.1

35.63

35.14

mmol/l

0.06

346

Congenital malformations of the musculoskeletal system, not elsewhere classified

3.13

2.23

7.6

1.8

45.11

38.83

mmol/l

—

Cachexia

5.65

2.22

1.2

1.7

28.00

35.44

mmol/l

—

Presence of other devices

114

850

1.32

2.21

1.3

1.1

32.05

36.00

mmol/l

1.34

101

724

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

457

1.45

2.21

1.2

33.36

34.39

mmol/l

0.17

395

Atopic dermatitis, strict definition with reimbursement

697

1.35

2.21

1.6

1.7

34.13

34.44

mmol/l

0.04

636

Malignant neoplasm of digestive organs

177

1083

1.25

2.18

1.3

1.2

35.29

33.32

mmol/l

0.55

161

912

Caries of enamel

388

2183

1.16

2.17

1.4

1.3

31.79

33.96

mmol/l

1.09

345

1932

Necrotizing fasciitis

4.38

2.16

1.0

39.67

31.00

mmol/l

—

Other deformities of toe(s)

2.03

2.16

1.1

29.92

32.10

mmol/l

0.20

Thyrotoxicosis with diffuse goitre

337

1.52

2.15

1.1

1.2

36.78

33.55

mmol/l

0.40

297

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

431

1.45

2.13

1.1

38.16

33.21

mmol/l

0.77

359

Dementia in Alzheimer disease

588

1.35

2.13

1.1

31.02

35.22

mmol/l

1.40

494

Radiculopathy

446

1.44

2.09

1.1

33.42

35.24

mmol/l

0.30

382

Outcome of delivery

164

0.45

2.09

1.6

1.3

37.67

31.10

mmol/l

0.40

150

Other disorders of veins

174

1381

1.24

2.08

1.1

1.2

32.81

33.80

mmol/l

0.25

147

1189

Motor disorders, excluding more controls

2.37

2.07

3.4

47.25

32.23

mmol/l

0.85

Melanocytic naevi

116

892

1.30

2.06

1.1

1.2

29.92

34.85

mmol/l

1.55

782

Other neurotic disorders

110

1.92

2.05

1.5

1.1

26.71

36.47

mmol/l

1.25

Polymyalgia rheumatica

474

1.42

2.03

1.2

1.1

32.95

35.17

mmol/l

0.40

392

Herpesviral [herpes simplex] infections, including avohilmo

686

1.34

2.03

1.4

1.2

31.70

33.75

mmol/l

0.31

597

ILD, hospital admissions 1, main diag only

441

1.43

2.02

1.3

1.1

33.32

34.71

mmol/l

0.22

383

Seborrhoeic dermatitis

286

1.54

2.02

1.1

1.3

30.31

36.43

mmol/l

0.81

254

Urticaria and erythema

137

1080

1.27

2.01

1.5

1.4

33.17

34.44

mmol/l

0.32

123

950

Dislocation, sprain and strain of joints and ligaments at neck level

335

1.50

2.00

1.2

32.95

36.50

mmol/l

0.49

302

Varicose veins

265

1685

1.19

1.99

1.1

1.2

33.43

33.65

mmol/l

0.06

238

1441

Inguinal hernia, bilateral

279

1.55

1.99

1.2

36.40

36.24

mmol/l

0.01

247

Crystal arthropathies, rheuma endpoint

2.30

1.98

1.2

37.38

33.49

mmol/l

—

Gonarthrosis [arthrosis of knee](FG)

300

1465

1.18

1.98

1.1

34.29

34.42

mmol/l

0.03

251

1288

Atopic dermatitis

209

1373

1.21

1.97

1.5

1.4

33.54

34.42

mmol/l

0.22

175

1232

Postviral fatigue syndrome

4.59

1.95

1.4

1.5

35.40

32.27

mmol/l

—

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

2.75

1.93

7.6

1.7

45.11

40.71

mmol/l

—

Other embolism and thrombosis

371

1.46

1.93

1.3

1.1

34.35

35.19

mmol/l

0.09

319

Glaucoma, exfoliation

388

1.45

1.92

1.0

1.1

31.24

34.53

mmol/l

0.56

318

Alzheimer disease

174

1010

1.23

1.91

1.1

34.64

35.22

mmol/l

0.12

139

854

Complications of labour and delivery

153

1057

0.80

1.90

1.1

1.2

31.83

32.30

mmol/l

0.10

137

919

1.94

1.90

4.9

2.8

36.84

35.29

mmol/l

0.10

Monoarthritis, not elsewhere classified

1.97

1.90

1.1

1.3

20.50

37.00

mmol/l

5.18

Sequelae of injuries of upper limb

243

1.57

1.89

1.1

1.2

36.50

35.78

mmol/l

0.05

219

Malignant neoplasm of kidney, except renal pelvis

267

1.54

1.89

1.1

35.45

33.84

mmol/l

0.16

227

Non-small cell lung cancer, including Hilmo

443

1.40

1.88

1.0

1.1

34.61

34.46

mmol/l

0.02

376

Other disorders of nervous system

181

1.66

1.88

1.3

1.2

31.10

35.50

mmol/l

0.48

161

Other hearing loss

134

1030

1.26

1.88

1.6

1.1

34.13

35.08

mmol/l

0.22

116

878

Injury of unspecified body region

212

1.61

1.88

1.5

1.3

31.11

35.40

mmol/l

0.39

192

Benign neoplasm: Skin of other and unspecified parts of face

300

1.50

1.87

1.2

1.1

31.94

35.82

mmol/l

0.54

258

Temporomandibular joint disorders, including avohilmo

148

1153

1.24

1.85

1.3

1.4

33.16

34.08

mmol/l

0.18

129

1011

Shoulder lesions

302

1548

1.17

1.84

1.2

33.75

34.09

mmol/l

0.09

265

1359

Superficial injury of ankle and foot

301

1.50

1.84

1.6

1.4

36.71

34.96

mmol/l

0.14

277

Striking against or struck by other objects

122

960

1.27

1.83

1.6

1.4

32.56

35.26

mmol/l

0.69

103

863

Alzheimer disease, including avohilmo

191

1090

1.21

1.82

1.1

35.52

34.93

mmol/l

0.12

152

926

Unspecific neurodegenerative disorder

213

1215

1.20

1.82

1.1

34.14

34.85

mmol/l

0.17

171

1028

Neonatal jaundice from other and unspecified causes

1.99

1.82

3.6

3.0

44.19

35.27

mmol/l

0.58

Inguinal or femoral hernia, bilateral

286

1.51

1.81

1.2

36.40

36.33

mmol/l

0.01

254

Fenamates

310

1.41

1.81

1.2

1.1

37.14

33.53

mmol/l

0.70

280

Tumor necrosis factor alpha inhibitors

385

1.43

1.80

1.9

1.3

37.37

35.54

mmol/l

0.16

352

Retinal detachments and breaks

153

1241

1.23

1.80

1.2

33.30

34.77

mmol/l

0.40

137

1061

Pleural plaque with presence of asbestos

207

1.60

1.79

1.1

35.78

34.99

mmol/l

0.08

181

Gonarthrosis

256

1223

1.18

1.79

1.1

1.2

33.29

34.30

mmol/l

0.28

216

1073

Scabies, including avohilmo

336

1.46

1.78

1.7

1.5

32.39

35.79

mmol/l

0.45

310

Special screening examination for infectious and parasitic diseases

285

1.43

1.78

1.3

1.1

37.20

34.66

mmol/l

0.27

261

Other strabismus

613

1.33

1.77

1.7

1.5

34.98

34.94

mmol/l

0.00

549

All dysplastic lesions of the cervix uteri, vagina or vulva

558

1.35

1.77

1.4

1.3

32.12

32.76

mmol/l

0.08

491

Coxibs

116

473

1.29

1.77

1.2

37.79

33.90

mmol/l

1.03

102

424

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

296

1.49

1.77

1.1

33.66

33.98

mmol/l

0.03

252

Thiazolidinediones

337

1.46

1.76

1.2

1.1

28.95

35.11

mmol/l

1.55

300

Other and unspecified tonsillitis

604

1.31

1.75

2.2

1.5

34.44

35.57

mmol/l

0.19

554

Otalgia

240

1.55

1.75

1.2

1.4

26.09

34.36

mmol/l

2.14

217

Benign neoplasm: Small intestine

117

1.81

1.74

1.4

1.1

28.12

36.06

mmol/l

1.52

106

Ill-defined and unknown causes of mortality

314

1.47

1.73

1.2

1.1

35.82

35.96

mmol/l

0.01

268

Spirochaetal infections, other/unspecified

241

1.54

1.73

1.1

1.2

43.03

34.75

mmol/l

0.85

214

Disorders of myoneural junction and muscle in diseases classified elsewhere

3.89

1.72

1.4

1.1

39.40

30.77

mmol/l

—

Other obstetric conditions, not elsewhere classified

263

1.42

1.72

1.4

1.5

34.53

33.26

mmol/l

0.15

242

Melanocytic naevi of trunk

323

1.46

1.71

1.1

1.2

28.92

35.14

mmol/l

1.02

289

Other disorders of conjunctiva

432

1.39

1.70

1.1

31.51

34.49

mmol/l

0.49

377

Abnormal serum enzyme levels

119

912

1.26

1.69

1.2

36.13

35.87

mmol/l

0.04

107

800

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

253

1.42

1.69

1.5

35.16

33.55

mmol/l

0.19

233

Synovial cyst of popliteal space [Baker]

187

1.61

1.69

1.2

36.73

33.16

mmol/l

0.49

156

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

458

1.38

1.68

1.6

1.2

34.31

35.68

mmol/l

0.18

410

Other congenital malformations of upper alimentary tract

3.21

1.67

2.2

2.1

23.83

36.28

mmol/l

—

Umbilical hernia

762

1.29

1.67

1.1

33.77

35.07

mmol/l

0.22

664

Other and unspecified types of non-Hodgkin lymphoma, hilmo

119

1.77

1.66

1.3

1.1

30.14

37.63

mmol/l

1.01

107

Disorders of puberty, all

2.46

1.65

7.7

2.1

22.13

35.13

mmol/l

—

Bilateral cryptorchidism (undescended testicles)

3.74

1.64

5.2

1.9

54.80

31.57

mmol/l

—

Pleural plaque

285

1.48

1.64

1.1

34.93

36.35

mmol/l

0.17

247

Other inflammation of eyelid

427

1.39

1.63

1.1

1.2

28.61

34.96

mmol/l

2.35

370

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

108

853

1.27

1.63

1.2

27.67

35.56

mmol/l

3.84

755

Aortic aneurysm

672

1.30

1.63

1.2

1.1

35.62

36.05

mmol/l

0.06

579

Disorders of puberty, other/unspecified

3.65

1.63

13.6

2.5

24.26

42.50

mmol/l

—

Other noninflammatory disorders of uterus, except cervix

507

1.29

1.62

1.1

31.91

32.38

mmol/l

0.08

433

Otitis externa

679

1.30

1.60

1.2

1.3

31.63

34.97

mmol/l

0.79

596

Anomalies of dental arch relationship, including avohilmo

457

1.35

1.58

2.1

1.7

30.17

35.65

mmol/l

1.63

420

Other fall from one level to another

663

1.30

1.57

1.4

37.13

35.58

mmol/l

0.20

601

Exposure to other and unspecified inanimate mechanical forces

191

1.58

1.56

1.8

1.2

30.74

36.90

mmol/l

0.83

178

Cholecystitis

432

1.37

1.54

2.2

1.1

33.50

34.82

mmol/l

0.16

373

Lesion of femoral nerve

3.37

1.53

1.2

1.1

22.80

36.20

mmol/l

—

Hereditary deficiency of other clotting factors

3.37

1.53

4.2

1.6

34.80

28.00

mmol/l

—

Measles

3.36

1.52

1.0

24.20

38.87

mmol/l

—

Measles, including avohilmo

3.36

1.52

1.0

24.20

38.87

mmol/l

—

Dentofacial anomalies [including malocclusion]

256

1729

1.16

1.51

1.4

1.3

32.82

33.48

mmol/l

0.17

226

1523

Cystic kidney disease

1.91

1.49

1.6

1.3

33.20

32.37

mmol/l

0.05

Single spontaneous delivery

125

812

0.81

1.47

1.1

1.2

33.05

33.26

mmol/l

0.04

107

704

Artificial joint operation, meniscal resection

387

2198

1.13

1.47

1.2

34.12

34.06

mmol/l

0.02

327

1915

Entropion and trichiasis of eyelid

268

1.46

1.1

1.2

38.00

35.95

mmol/l

0.19

231

Inflammatory diseases of female pelvic organs

237

1395

1.16

1.46

1.4

1.2

31.27

32.58

mmol/l

0.43

212

1205

Other congenital malformations of brain

3.18

1.44

11.4

2.5

23.00

31.81

mmol/l

—

Alzheimer’s disease (Late onset)

122

816

1.23

1.44

1.1

34.59

35.21

mmol/l

0.11

688

Cholelithiasis

333

2004

1.13

1.44

1.3

1.1

34.86

34.22

mmol/l

0.21

283

1743

Other ill-defined and unspecified causes of mortality

286

1.44

1.43

1.1

36.33

36.01

mmol/l

0.03

246

105

1.74

1.42

5.1

2.7

38.16

36.18

mmol/l

0.13

105

Delivery

127

816

0.82

1.39

1.1

1.2

33.48

33.23

mmol/l

0.04

109

707

Ganglion

545

1.30

1.38

1.3

35.30

34.37

mmol/l

0.10

480

Etanercept

142

1.62

1.38

1.6

1.3

31.31

36.94

mmol/l

0.65

133

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

407

1.35

1.37

1.7

1.2

34.18

35.95

mmol/l

0.22

367

Injuries to the wrist and hand

411

2441

1.12

1.37

1.3

35.88

33.64

mmol/l

1.07

350

2151

Coxarthrosis, primary

268

1946

1.14

1.36

1.1

32.98

34.05

mmol/l

0.35

226

1678

Acute appendicitis, no complications

183

1549

1.17

1.36

1.4

1.2

35.10

34.14

mmol/l

0.22

160

1368

Carpal tunnel syndrome

242

1824

1.15

1.34

1.2

32.21

34.26

mmol/l

0.79

208

1593

Superficial injury of shoulder and upper arm

315

1.40

1.34

1.2

27.07

36.31

mmol/l

1.99

283

Benign neoplasm: Sigmoid colon

627

1.28

1.34

1.3

1.1

33.42

35.02

mmol/l

0.23

545

Ulcerative colitis (strict definition, require KELA)

426

1.34

1.6

1.2

34.41

35.70

mmol/l

0.16

385

Specific developmental disorder of motor function

1.88

1.34

3.3

2.8

47.51

35.30

mmol/l

0.72

Nonspecific lymphadenitis

120

1.67

1.34

1.1

31.20

35.81

mmol/l

0.42

110

Thoracic aortic aneurysm

409

1.35

1.34

1.3

1.1

34.96

36.80

mmol/l

0.22

357

Benign paroxysmal vertigo

128

1059

1.21

1.33

1.1

1.2

34.04

34.23

mmol/l

0.03

106

901

Other maternal disorders predominantly related to pregnancy

131

988

0.83

1.32

1.2

1.3

33.09

31.89

mmol/l

0.25

119

866

Vasomotor rhinitis (mode)

184

1.53

1.31

1.6

1.1

32.91

35.99

mmol/l

0.34

166

Carbimazole or st.post thyroidectomy, condition for graves disease

585

1.28

1.31

1.1

1.2

35.21

33.36

mmol/l

0.28

505

Other female pelvic inflammatory diseases

454

1.32

1.31

1.3

1.2

31.31

33.13

mmol/l

0.28

384

Atopic dermatitis, strict definition

702

1.25

1.30

1.6

1.8

36.28

34.68

mmol/l

0.25

641

Effects of foreign body entering through natural orifice

692

1.26

1.30

1.2

1.3

28.94

36.04

mmol/l

2.99

622

Conjunctivitis (acute, non atopic)

104

841

1.23

1.29

1.2

1.5

27.80

34.43

mmol/l

3.44

748

Oxicams

430

1.26

1.29

1.1

36.33

33.90

mmol/l

0.43

383

Nonsuppurative otitis media, including avohilmo

102

714

1.24

1.28

2.0

1.6

32.00

34.82

mmol/l

0.68

637

Mixed specific developmental disorders

1.77

1.28

1.8

3.0

34.56

34.42

mmol/l

0.01

Familial hypercholesterolemia, with ischemic heart disease

293

1.40

1.28

1.1

32.22

34.84

mmol/l

0.32

244

Adalimumab

210

1.48

1.27

2.3

1.2

40.08

37.59

mmol/l

0.13

194

Benign lipomatous neoplasm

939

0.79

1.27

1.1

33.82

34.26

mmol/l

0.06

817

Rosacea

336

1.37

1.26

1.1

37.02

33.88

mmol/l

0.34

299

Disorders of puberty

2.24

1.24

9.1

1.8

21.79

32.69

mmol/l

—

Primary coxarthrosis, bilateral

131

1095

1.20

1.24

1.1

1.2

33.69

34.25

mmol/l

0.10

107

928

Haemorrhage in early pregnancy

602

0.74

1.24

1.3

35.17

32.99

mmol/l

0.31

532

Presbycusis

531

1.29

1.23

1.2

1.1

34.58

34.95

mmol/l

0.05

438

Open wound of wrist and hand

151

1235

1.18

1.23

1.3

34.53

34.32

mmol/l

0.04

129

1108

Seborrhoeic keratosis

105

860

1.22

1.23

1.2

34.47

35.09

mmol/l

0.10

740

Artrosis, including avohilmo

318

1547

1.13

1.23

1.1

1.2

34.48

34.35

mmol/l

0.04

274

1371

Other inflammation of eyelid, including avohilmo

154

1308

1.18

1.22

1.2

1.3

30.68

34.33

mmol/l

1.59

135

1153

Diseases of external ear

140

1181

1.19

1.20

1.3

1.2

32.49

34.69

mmol/l

0.62

126

1027

Other abnormal products of conception

354

0.72

1.20

1.3

1.4

32.00

31.63

mmol/l

0.03

324

Suppurative and unspecified otitis media

109

794

1.22

1.20

1.5

1.6

30.86

35.12

mmol/l

1.31

711

Benign neoplasm of breast

357

1.35

1.19

1.2

1.1

32.95

33.67

mmol/l

0.07

308

Other and unspecified epidermal thickening

1.84

1.19

1.8

1.2

44.93

33.66

mmol/l

0.55

Cystic kidney disease, including avohilmo

1.75

1.19

1.6

1.3

33.20

34.25

mmol/l

0.06

Toxic effect of ethanol

1.88

1.18

6.4

1.2

42.08

36.77

mmol/l

0.30

Wet age-related macular degeneration

711

1.24

1.18

1.1

34.90

35.66

mmol/l

0.13

590

Pediculosis, acariasis and other infestations, including avohilmo

436

1.31

1.18

1.6

1.4

34.03

35.10

mmol/l

0.11

394

Fracture at wrist and hand level

123

1025

1.20

1.17

1.4

1.3

33.84

34.24

mmol/l

0.07

107

914

Coxarthrosis, primary, with hip surgery

211

1709

1.15

1.16

1.1

1.2

32.84

34.30

mmol/l

0.44

177

1467

Scabies

102

1.67

1.16

1.4

1.2

27.53

39.58

mmol/l

1.29

Trigger finger

385

1.33

1.16

1.2

32.54

34.26

mmol/l

0.25

335

Other skin changes

668

1.24

1.16

1.4

1.2

33.28

34.88

mmol/l

0.25

573

Social disorders starting during childhood or adolescence

2.52

1.15

2.8

3.3

26.00

42.16

mmol/l

—

Alzheimer’s disease (undefined)

0.00

1.15

0.0

1.1

—

32.94

—

Excessive, frequent and irregular menstruation

135

606

1.19

1.12

2.3

1.2

31.39

33.16

mmol/l

0.44

117

527

Use of memantine

141

965

1.18

1.10

1.1

32.40

35.21

mmol/l

0.89

112

815

Use of other anti-dementia drugs

141

965

1.18

1.10

1.1

32.40

35.21

mmol/l

0.89

112

815

Alzheimer’s disease (Atypical or mixed)

427

1.30

1.09

1.1

31.91

35.08

mmol/l

0.66

351

Pre-eclampsia or eclampsia

468

1.28

1.09

1.2

1.3

26.76

33.50

mmol/l

2.28

410

Malignant neoplasm of small intestine

1.83

1.09

2.0

1.2

30.41

33.65

mmol/l

0.27

Malignant neoplasm of mesothelium and soft tissue

120

1.59

1.08

1.0

1.3

28.13

33.65

mmol/l

0.73

104

Carcinoma in situ of skin of scalp and neck

1.70

1.08

1.1

39.93

36.01

mmol/l

0.35

Rare circulating lymphoid malignancy, including Hilmo

1.69

1.07

1.9

2.1

29.40

35.64

mmol/l

0.66

Use of donepezil

853

0.80

1.07

1.1

32.93

34.99

mmol/l

0.37

709

Benign neoplasm: Duodenum

1.77

1.07

1.5

1.1

28.68

35.81

mmol/l

0.78

Dermatophytosis

417

1.30

1.07

1.1

1.2

33.35

35.61

mmol/l

0.32

368

Non-Hodgkin lymphoma, all

121

1.58

1.05

1.3

1.2

29.42

33.49

mmol/l

0.55

105

Myocardial infarction, with ST-elevation

534

1.26

1.04

1.1

36.74

35.91

mmol/l

0.10

459

Social disorders starting during childhood or adolecense, excluding more controls

2.29

1.03

2.8

3.8

26.00

35.95

mmol/l

—

Other disorders of bone

482

1.27

1.02

1.1

1.2

27.60

35.38

mmol/l

2.52

427

Meniscus derangement

210

1227

1.14

1.02

1.2

36.07

34.28

mmol/l

0.54

183

1080

Pulmonary oedema

1.88

1.00

1.0

1.1

31.47

30.60

mmol/l

—

Impingement syndrome of shoulder

672

1.22

1.00

1.1

1.2

37.97

34.05

mmol/l

0.77

597

Motor disorders

1.69

1.00

3.3

2.8

47.51

33.49

mmol/l

0.88

Oter anti-inflammatory and antirheumatic agents, non-steroids

411

1.22

0.99

1.2

1.1

36.49

33.49

mmol/l

0.65

364

Other disorders of penis

265

1.36

0.99

1.5

1.3

40.89

34.82

mmol/l

0.50

243

Enteropathic arthropathies

1.84

0.98

1.0

1.2

40.03

37.98

mmol/l

—

Superficial injury of wrist and hand

557

1.24

0.97

1.5

1.3

36.19

33.82

mmol/l

0.31

498

Rotator cuff syndrome

240

1473

1.12

0.97

1.2

33.28

34.01

mmol/l

0.20

214

1292

Hypertrichosis

1.95

0.97

1.0

1.4

27.14

40.92

mmol/l

—

Follicular cysts of skin and subcutaneous tissue

533

1.24

0.94

1.2

27.04

36.11

mmol/l

4.09

472

Erosion and ectropion of cervix uteri

1.72

0.92

1.1

24.50

32.37

mmol/l

1.28

Alzheimer’s disease, strict definition

126

873

1.17

0.92

1.1

35.01

35.20

mmol/l

0.03

101

741

Haemorrhoids and perianal venous thrombosis

123

1052

1.16

0.89

1.2

1.1

34.03

34.83

mmol/l

0.15

111

908

Delivery, wide proxy

112

696

0.85

0.89

1.1

1.2

35.63

32.94

mmol/l

0.56

604

Ovarian cyst

117

571

1.17

0.88

1.5

1.1

34.62

32.27

mmol/l

0.52

102

496

Polyp of the female genital tract

114

550

1.17

0.88

1.1

35.48

32.33

mmol/l

0.72

101

476

Deviated nasal septum

109

932

1.17

0.86

1.2

1.1

35.02

35.25

mmol/l

0.04

833

Female genital prolapse

114

541

1.17

0.86

1.2

1.1

35.29

32.24

mmol/l

0.77

466

Nail disorders

221

1.36

0.85

1.2

28.12

35.55

mmol/l

1.31

202

Pregnancy, childbirth and the puerperium

104

637

0.85

1.1

1.3

35.24

33.58

mmol/l

0.30

546

Diseases of middle ear and mastoid

192

1396

1.12

0.85

1.4

31.66

34.74

mmol/l

1.27

174

1230

Postmenopausal bleeding

115

515

1.17

0.84

1.1

32.27

32.11

mmol/l

0.03

440

Pregnancy with abortive outcome

203

1184

0.89

0.84

1.1

1.2

33.17

32.52

mmol/l

0.16

174

1028

Pedal cyclist injured in transport accident

632

1.20

0.84

1.7

1.2

37.26

35.49

mmol/l

0.20

561

Disorders of vitreous body and globe

214

1816

1.11

0.84

1.2

1.1

35.78

33.49

mmol/l

0.84

188

1572

Malignant neoplasm of corpus uteri

300

1.30

0.84

1.0

1.1

32.85

33.07

mmol/l

0.02

245

Tinnitus

734

1.19

0.83

1.1

36.41

35.51

mmol/l

0.13

636

Spontaneous abortion

110

855

0.86

0.82

1.1

1.2

30.68

32.13

mmol/l

0.36

748

Noninflammatory disorders of female genital tract

139

607

1.15

0.82

1.3

1.2

33.98

33.13

mmol/l

0.16

123

528

Hirsutism in women

1.88

0.82

1.0

1.5

28.67

41.47

mmol/l

—

malignant neoplasm of male genital organs, including Hilmo

494

1.18

0.82

1.1

1.2

38.01

34.10

mmol/l

0.96

433

Gonarthrosis, primary, with knee surgery

254

1792

1.10

0.81

1.2

1.1

33.92

33.55

mmol/l

0.09

218

1548

Amputation of ankle bones

1.73

0.80

1.1

29.90

33.47

mmol/l

—

Birth asphyxia

1.84

0.79

1.8

2.4

32.37

35.70

mmol/l

—

Lyme disease, including avohilmo

1055

0.85

0.79

1.1

1.2

39.91

34.49

mmol/l

1.07

923

Lyme disease

1055

0.85

0.79

1.1

1.2

39.91

34.49

mmol/l

1.07

923

DVT of lower extremities

591

1.20

0.79

1.2

1.1

32.91

35.20

mmol/l

0.37

498

Other and unspecified injuries of wrist and hand

1.54

0.78

1.1

1.5

38.38

35.87

mmol/l

—

conjunctival haemorrhage

225

1.34

0.78

1.1

1.2

31.41

35.18

mmol/l

0.47

194

Spirochaetal infections, other/unspecified, including avohilmo

1063

0.86

0.77

1.1

1.2

40.52

34.38

mmol/l

1.28

930

Reactive arthropathies, FINNGEN

165

1.40

0.77

1.1

1.2

45.18

34.24

mmol/l

1.14

149

Malignant neoplasm of breast, including Hilmo

159

902

1.13

0.77

1.3

1.2

34.39

31.51

mmol/l

0.98

145

755

Other infections specific to the perinatal period

0.00

0.76

0.0

1.9

—

41.36

—

Retinal detachment with retinal break

403

1.24

0.76

1.2

30.31

35.12

mmol/l

1.04

345

Malignant neoplasm of breast, HER2-negative, including Hilmo

159

903

1.13

0.76

1.3

1.2

34.39

31.50

mmol/l

0.98

145

756

Parkinson's disease, including avohilmo

540

1.21

0.75

1.1

34.60

35.19

mmol/l

0.09

459

Acquired haemolytic anaemia

1.65

0.75

1.1

29.27

35.36

mmol/l

0.53

Cardiovascular disorders originating in the perinatal period

2.12

0.75

8.4

3.0

30.20

33.21

mmol/l

—

Sudden idiopathic hearing loss

288

1.29

0.75

1.1

33.03

34.77

mmol/l

0.20

249

Malignant neoplasm of small intestine, including Hilmo

1.57

0.75

2.0

1.2

28.99

33.68

mmol/l

0.45

Other spirochaetal diseases

1069

0.86

0.74

1.2

41.04

34.49

mmol/l

1.41

937

Appendectomy

220

1901

1.10

0.73

1.3

1.2

34.48

33.47

mmol/l

0.23

196

1667

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

1.81

0.72

1.0

1.1

40.69

34.03

mmol/l

—

Use of ropinirole

107

0.56

0.72

1.0

1.1

20.67

35.60

mmol/l

—

Injury of muscle and tendon at hip and thigh level

265

0.72

1.8

1.2

46.09

36.59

mmol/l

0.45

238

Tuberculosis of other organs, strict

1.62

0.72

1.3

1.2

29.55

34.72

mmol/l

0.51

Other/unspecified reactive arthropathies

151

1.39

0.71

1.1

1.2

46.20

37.07

mmol/l

0.81

139

Other spirochaetal diseases, including avohilmo

1085

0.87

0.70

1.2

41.62

34.35

mmol/l

1.64

951

Triptan medication for migraine, min. 3 purchases

163

1089

1.12

0.70

1.3

33.27

33.35

mmol/l

0.02

148

962

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

307

1.26

0.70

2.9

1.9

41.03

35.64

mmol/l

0.45

291

Other abnormal uterine and vaginal bleeding

522

1.17

0.70

1.3

1.1

31.70

32.60

mmol/l

0.14

449

Disorders of vitreous body

206

1778

1.10

0.70

1.2

1.1

35.53

33.50

mmol/l

0.70

182

1539

Primary open-angle glaucoma

142

1215

1.13

0.70

1.1

31.28

34.87

mmol/l

1.36

122

1017

Fetus and newborn affected by maternal complications of pregnancy

1.69

0.69

2.7

2.9

24.57

34.43

mmol/l

—

Tuberculosis of other organs

1.65

0.68

1.3

1.2

29.30

35.51

mmol/l

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

161

1.37

0.68

1.5

1.2

33.14

36.39

mmol/l

0.36

146

Primary gonarthrosis, bilateral

224

1712

1.10

0.67

1.2

1.1

34.85

33.51

mmol/l

0.39

191

1483

Parkinson's disease

511

1.20

0.67

1.1

34.16

35.27

mmol/l

0.17

438

Other specified disorders of kidney and ureter

0.55

0.67

1.6

1.2

22.80

33.77

mmol/l

—

Malignant neoplasm of prostate, including Hilmo

485

1.16

0.66

1.1

1.2

37.78

34.33

mmol/l

0.78

424

Other benign neoplasm of uterus: Other parts/unspecified

145

1.38

0.66

1.1

1.2

39.87

34.04

mmol/l

0.49

125

Tuberculosis of other organs, strict, including avohilmo

1.58

0.65

1.3

1.2

29.55

35.33

mmol/l

0.60

Nasal polyp

527

0.82

0.65

1.2

1.1

38.73

35.59

mmol/l

0.38

473

Sarcoidosis

376

1.23

0.65

1.2

30.81

35.35

mmol/l

0.92

331

Glucosamine medication

208

1514

1.10

0.64

1.1

35.54

33.76

mmol/l

0.48

174

1287

Contraceptive management

723

0.87

0.64

1.2

1.3

36.72

32.84

mmol/l

0.83

649

Uterine polyps

105

537

1.14

0.63

1.2

1.1

34.17

32.13

mmol/l

0.42

465

Appendicitis, broad definition

253

2091

1.09

0.63

1.3

1.2

33.95

33.89

mmol/l

0.01

227

1829

Malignant neoplasm of corpus uteri, including Hilmo

333

1.23

0.62

1.0

1.1

32.61

32.71

mmol/l

0.01

269

Adenocarcinoma and papillary adenocarcinoma of stomach

1.55

0.62

1.1

1.2

41.00

35.59

mmol/l

0.17

Abrasion of teeth

124

1106

1.12

0.61

1.2

31.03

34.42

mmol/l

0.99

112

966

Pedal cyclist injured in noncollision transport accidents

307

1.24

0.60

1.9

1.3

36.19

36.59

mmol/l

0.03

281

Alzheimer’s disease (undefined), excluding more controls

0.00

0.60

0.0

1.1

—

33.29

—

Sulfonylureas

141

1006

1.11

0.60

1.2

1.1

28.94

35.15

mmol/l

3.92

116

857

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

0.00

0.60

0.0

1.0

—

33.97

—

Diseases of appendix

255

2107

1.08

0.60

1.3

1.2

34.02

33.88

mmol/l

0.03

228

1843

Disorders of eyelid in diseases classified elsewhere

1.50

0.60

1.1

1.3

26.04

35.06

mmol/l

0.93

Mesial bite

0.00

0.59

0.0

2.0

—

39.00

—

Birth trauma

0.00

0.58

0.0

2.7

—

45.22

—

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

1.51

0.58

1.1

1.2

32.88

35.60

mmol/l

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

418

1.20

0.58

1.2

31.38

33.40

mmol/l

0.28

366

Bacterial sepsis of newborn

1.73

0.58

4.8

2.1

51.33

38.74

mmol/l

—

Corneal ulcer

520

1.17

0.57

1.2

32.31

35.17

mmol/l

0.54

453

Benign thyroid growths and nodules

126

1050

1.12

0.57

1.1

1.2

32.13

34.27

mmol/l

0.60

107

913

Heterophoria

193

1.30

0.57

1.9

1.4

35.59

35.62

mmol/l

0.00

179

Conjunctivitis (acute, non atopic), including avohilmo

395

2241

1.06

0.57

1.2

1.3

33.84

34.05

mmol/l

0.06

346

1978

Malignant neoplasm of pancreas, including Hilmo

274

1.24

0.56

1.1

28.68

32.29

mmol/l

0.86

234

Postmenopausal atrophic vaginitis

105

506

1.13

0.56

1.2

1.1

35.41

31.84

mmol/l

0.73

436

Propionic acid derivatives

117

525

1.12

0.54

1.2

1.6

36.12

34.21

mmol/l

0.42

108

476

Other benign neoplasms of uterus

177

1.30

0.54

1.1

39.28

34.31

mmol/l

0.50

151

Other menopausal disorders

474

0.87

0.54

1.4

1.1

30.21

31.91

mmol/l

0.30

412

Other and specified injuries of hip and thigh

1.48

0.53

1.2

40.89

36.66

mmol/l

—

Muscle strain

1.48

0.53

1.2

1.1

25.79

36.42

mmol/l

—

Leiomyoma of uterus

205

1247

0.92

0.53

1.1

1.2

33.92

32.18

mmol/l

0.48

170

1081

Pre-eclampsia

432

1.18

0.53

1.2

27.15

33.55

mmol/l

1.84

381

Malignant neoplasm of breast, HER-positive

125

838

1.11

0.53

1.2

1.1

32.73

31.64

mmol/l

0.22

114

699

Circumscribed brain atrophy

1.52

0.52

1.2

1.1

20.00

34.92

mmol/l

—

Hallux rigidus

405

1.19

0.52

1.2

31.87

34.55

mmol/l

0.36

353

Malignant neoplasm of breast, ER-positive, including Hilmo

125

838

1.11

0.52

1.2

1.1

32.73

31.64

mmol/l

0.22

114

699

Urticaria

854

1.12

0.52

1.3

1.4

31.48

34.39

mmol/l

0.86

749

Benign neoplasm: Pancreas

1.45

0.52

1.1

30.67

36.13

mmol/l

0.60

Acute appendicitis

230

1982

1.08

0.51

1.3

1.2

34.40

33.97

mmol/l

0.10

204

1737

Infectious mononucleosis, including avohilmo

136

0.66

0.51

1.0

1.4

23.33

37.18

mmol/l

—

130

Infectious mononucleosis

136

0.66

0.51

1.0

1.4

23.33

37.18

mmol/l

—

130

Preterm labour and delivery

592

1.15

0.51

1.2

1.3

31.98

31.88

mmol/l

0.01

521

Recurrent dislocation and subluxation of joint

135

1.33

0.51

1.7

1.2

31.89

36.92

mmol/l

0.59

122

Plantar fascial fibromatosis

233

1.25

0.50

1.1

38.55

33.41

mmol/l

0.59

201

Phlebitis and thrombophlebitis (not including DVT)

697

1.13

0.50

1.2

37.34

34.50

mmol/l

0.40

591

Benign neoplasm: Parotid gland

207

1.26

0.49

1.1

43.01

34.75

mmol/l

0.57

186

Benign neoplasm of ovary

557

1.15

0.49

1.3

1.2

35.45

33.38

mmol/l

0.31

470

Maternal care related to the fetus and amniotic cavity and possible delivery problems

586

0.89

0.48

1.2

1.3

34.75

32.15

mmol/l

0.51

521

Respiratory and cardiovascular disorders specific to the perinatal period

114

1.34

0.48

3.4

3.2

37.48

35.27

mmol/l

0.14

114

Malignant neoplasm of breast, HER2-negative

152

897

1.09

0.48

1.2

34.80

31.51

mmol/l

1.14

140

750

Malignant neoplasm of breast

152

897

1.09

0.48

1.2

34.80

31.51

mmol/l

1.14

140

750

Malignant neoplasm of larynx, including Hilmo

1.49

0.47

1.0

1.1

31.86

33.70

mmol/l

—

Macular pucker

559

1.15

0.47

1.2

1.1

34.60

34.94

mmol/l

0.03

478

Anti-inflammatory and antirheumatic products, non-steroids

116

526

1.11

0.47

1.2

1.6

35.91

34.23

mmol/l

0.35

108

477

Internal derangement of knee

123

1107

1.10

0.47

1.2

33.12

34.69

mmol/l

0.31

972

Parkinson's disease, strict definition

476

1.16

0.46

1.1

34.99

34.94

mmol/l

0.01

411

Inguinal hernia, unilateral

0.60

0.45

1.2

30.00

35.48

mmol/l

—

Femoral hernia, unilateral

0.60

0.45

1.2

30.00

35.48

mmol/l

—

Inguinal of femoral hernia, unilateral

0.60

0.45

1.2

30.00

35.48

mmol/l

—

Benign lipomatous neoplasm of other sites/unspecified

246

1.22

0.45

1.2

35.46

35.47

mmol/l

0.00

214

Triptan medication for migraine, single purchase ok

254

1612

1.07

0.45

1.3

34.88

33.58

mmol/l

0.43

224

1420

Migraine, single triptan purchase ok & required. ICD-code if available is included

254

1612

1.07

0.45

1.3

34.88

33.58

mmol/l

0.43

224

1420

Suggestive for eosinophilic asthma

242

0.78

0.44

1.1

39.19

34.44

mmol/l

0.42

215

Idiopathic gout

284

1.20

0.43

1.2

1.1

28.21

36.97

mmol/l

1.57

250

Spondyloarthritis

470

1.15

0.43

1.5

1.1

36.40

35.46

mmol/l

0.11

406

ILD-related respiratory insufficiency

104

1.35

0.43

1.2

33.54

33.95

mmol/l

0.04

Other and unspecified rosacea

239

1.21

0.42

1.2

1.1

34.63

34.99

mmol/l

0.02

212

Ulcerative colitis (strict definition, all Crohn cases excluded)

359

1.17

0.42

1.4

1.2

34.04

35.63

mmol/l

0.16

327

Tooth eruption problems

293

1.19

0.42

2.3

35.08

36.61

mmol/l

0.12

281

Use of levodopa decarbox-comt-inhibitor

0.63

0.42

1.3

1.2

28.50

35.69

mmol/l

—

Cervical root disorders

0.00

0.41

0.0

1.0

—

36.08

—

Use of levodopa decarboxylase inhibitor

464

1.14

0.40

1.2

1.1

38.34

34.93

mmol/l

0.62

402

Constitutional tall stature

0.00

0.40

0.0

2.2

—

35.78

—

Muscle wasting and atrophy, not elsewhere classified

0.00

0.40

0.0

1.1

—

32.11

—

Ulcerative rectosigmoiditis

168

1.25

0.40

1.2

24.56

36.20

mmol/l

1.39

156

Benign neoplasm: Caecum

352

1.17

0.40

1.1

37.10

35.11

mmol/l

0.24

305

Other disorders originating in the perinatal period

1.32

0.40

7.5

2.8

23.29

36.82

mmol/l

—

Benign neoplasm of major salivary glands

269

1.19

0.39

1.1

42.57

34.57

mmol/l

0.74

234

Use of rivastigmine

643

1.12

0.39

1.1

35.39

34.20

mmol/l

0.16

531

Polyarthritis, unspecified

1.38

0.38

1.6

1.3

35.13

34.75

mmol/l

0.02

Periodontal disease, other/unspecified

1.37

0.38

1.7

1.3

34.33

37.20

mmol/l

—

Dermatitis due to ingested food

119

1.29

0.37

5.8

3.6

45.23

36.66

mmol/l

0.54

119

Chondropathies

392

1.15

0.37

1.1

1.2

27.64

36.07

mmol/l

2.21

352

Use of galantamine

290

1.17

0.36

1.1

32.70

34.78

mmol/l

0.22

235

Bacterial, viral and other infectious agents, including avohilmo

216

1.21

0.36

1.6

1.3

31.50

36.34

mmol/l

0.49

202

Malignant neoplasm of breast, ER-negative, including Hilmo

704

1.10

0.36

1.3

1.1

37.50

32.16

mmol/l

1.71

580

Gonarthrosis,primary

360

2072

1.05

0.36

1.1

1.2

34.85

33.71

mmol/l

0.41

299

1810

Colorectal cancer, including Hilmo

104

890

1.09

0.36

1.3

1.2

37.09

33.46

mmol/l

0.97

749

Polyhydramnios

0.65

0.35

1.0

1.3

20.38

35.44

mmol/l

—

Toxic effect of contact with venomous animals

108

1.30

0.35

1.1

1.3

33.29

35.28

mmol/l

0.17

103

Antepartum haemorrhage, not elsewhere classified

117

1.28

0.35

1.0

1.7

42.60

35.84

mmol/l

0.37

104

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

1.35

0.35

5.8

3.2

26.00

34.94

mmol/l

0.66

Ménière disease

292

1.17

0.34

1.1

30.91

35.05

mmol/l

0.56

254

Malignant neoplasm of prostate

475

1.10

0.33

1.1

1.2

38.29

34.13

mmol/l

0.98

414

Lichen sclerosus et atrophicus

359

1.14

0.33

1.3

1.1

29.41

32.94

mmol/l

0.54

309

Pregnancy hypertension

105

866

1.08

0.33

1.2

1.3

29.75

32.78

mmol/l

0.82

756

Transitory endocrine and metabolic disorders specific to fetus and newborn

1.34

0.32

5.8

3.2

26.00

34.84

mmol/l

0.65

Malignant neoplasm of other connective and soft tissue

1.35

0.32

1.0

1.4

27.74

35.01

mmol/l

—

Combinations of oral blood glucose lowering drugs

894

1.09

0.32

1.1

33.35

35.08

mmol/l

0.37

778

Bronchitis, not specified as acute or chronic

201

1.20

0.32

1.6

1.1

39.76

34.33

mmol/l

0.53

179

Unspecified lump in breast

474

1.12

0.31

1.2

28.49

33.50

mmol/l

1.23

407

Female infertility

397

1.10

0.31

1.2

1.1

30.47

32.43

mmol/l

0.36

350

Anogenital herpesviral [herpes simplex] infection, including avohilmo

183

1.20

0.31

1.5

1.3

34.23

35.90

mmol/l

0.13

172

Personal history of malignant neoplasm

239

1.17

0.31

1.6

1.2

32.45

32.81

mmol/l

0.03

211

Carcinoma in situ of skin of upper limb, including shoulder

0.72

0.31

1.0

1.2

27.86

34.71

mmol/l

—

malignant neoplasm of male genital organs

492

1.09

0.31

1.1

1.2

38.54

34.19

mmol/l

1.07

431

Foreign body in respiratory tract

138

1.23

0.30

1.2

1.3

26.90

36.52

mmol/l

1.79

127

Malignant neoplasm of other connective and soft tissue, including Hilmo

120

1.25

0.30

1.0

1.3

39.36

34.22

mmol/l

0.26

106

Benign neoplasm: salivary glands, exclude unknown (D119)

231

1.17

0.29

1.1

42.69

34.32

mmol/l

0.62

204

Hydrocele

306

1.14

0.29

1.2

33.36

35.97

mmol/l

0.34

268

Bacterial, viral and other infectious agents

194

1.19

0.29

1.7

1.3

31.87

35.96

mmol/l

0.35

182

Injury of muscle and tendon at wrist and hand level

354

1.13

0.29

1.1

1.2

32.88

35.35

mmol/l

0.28

316

Adenomyosis (Endometriosis of uterus)

395

0.88

0.27

1.1

28.93

32.59

mmol/l

0.68

341

Benign neoplasm: Larynx

1.21

0.26

1.1

1.2

25.63

33.65

mmol/l

—

Menorrhagia

110

575

1.07

0.24

1.3

1.2

29.38

32.69

mmol/l

1.01

498

Dental pulpitis, including avohilmo

306

1888

1.04

0.24

1.4

1.2

31.45

34.17

mmol/l

1.50

269

1673

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

1.27

0.24

4.1

3.2

28.55

35.73

mmol/l

0.66

N06DA Anticholinesterases

158

1159

1.05

0.23

1.1

34.89

35.10

mmol/l

0.04

129

980

Use of anticholinesterases

158

1159

1.05

0.23

1.1

34.89

35.10

mmol/l

0.04

129

980

Other vitreous opacities

115

1.22

0.23

1.0

1.1

36.03

34.25

mmol/l

0.10

104

Female infertility, cervical, vaginal, other or unspecified origin

383

1.09

0.23

1.2

1.1

31.46

32.56

mmol/l

0.17

340

Malignant melanoma, including Hilmo

534

1.09

0.22

1.1

30.35

33.83

mmol/l

0.73

448

Other appendicitis

200

1.15

0.22

1.0

1.2

29.96

35.13

mmol/l

0.93

179

Reiter disease

0.00

0.21

0.0

1.0

—

32.50

—

Use of fingolimod

0.00

0.21

0.0

1.1

—

41.20

—

Use of teriflunomide

0.00

0.21

0.0

1.1

—

37.80

—

Other congenital malformations of tongue, mouth and pharynx

1.19

0.21

2.4

2.2

48.00

37.08

mmol/l

—

Endometriosis

103

564

1.06

0.21

1.2

1.1

32.91

32.13

mmol/l

0.13

489

Chondrosarcoma

0.00

0.21

0.0

1.1

—

27.92

—

Mucinous and mucinous cystic tumor

0.00

0.21

0.0

1.0

—

28.67

—

Benign neoplasm: Kidney

101

0.79

0.21

1.1

28.96

36.47

mmol/l

—

Endometriosis of ovary

423

1.09

0.21

1.2

1.1

31.15

32.22

mmol/l

0.14

369

Benign neoplasm: Skin of eyelid, including canthus

498

1.08

0.21

1.2

1.1

36.84

34.39

mmol/l

0.30

427

Malignant neoplasm of penis, including Hilmo

0.00

0.21

0.0

1.1

—

27.18

—

Melanoma in situ of lower limb, including hip

0.00

0.21

0.0

1.1

—

27.92

—

Endometriosis ASRM stages 3,4

624

1.07

0.20

1.2

30.23

33.46

mmol/l

0.73

533

Femoral hernia

123

0.81

0.20

1.1

34.90

35.33

mmol/l

—

109

Noise effects on inner ear

1.22

0.19

1.1

33.90

36.82

mmol/l

0.27

Vestibular neuronitis

241

1.12

0.19

1.3

1.1

29.00

35.08

mmol/l

0.85

217

Benign leiomyoma with endometriosis

519

0.92

0.18

1.0

1.1

30.47

33.38

mmol/l

0.43

439

Benign neoplasm: Ascending colon

473

1.08

0.18

1.2

1.1

30.56

35.16

mmol/l

0.80

410

Anogenital herpesviral [herpes simplex] infection

100

1.20

0.18

1.3

1.2

33.67

35.40

mmol/l

0.10

Other disorders of breast

368

1.09

0.17

1.4

1.2

32.09

33.49

mmol/l

0.17

325

Lichen planus, including avohilmo

612

1.06

0.16

1.1

1.2

34.89

34.01

mmol/l

0.10

525

Abnormal findings in secretions and smears from cervix uteri vagina vulva

125

958

0.96

0.16

1.4

1.2

32.94

32.27

mmol/l

0.12

112

833

Other disorders of male genital organs

1.15

0.15

1.0

1.2

41.64

33.49

mmol/l

—

Mouth breathing

118

1227

0.96

0.15

1.6

1.3

34.12

34.87

mmol/l

0.13

107

1091

Malignant neoplasm of rectosigmoid junction, including Hilmo

1.14

0.15

1.0

1.2

46.96

34.95

mmol/l

—

Malignant melanoma

478

1.07

0.15

1.1

29.60

34.00

mmol/l

0.95

402

Serous carcinoma of ovary, including Hilmo

1.18

0.14

1.1

1.2

31.65

32.37

mmol/l

0.03

Benign neoplasm of middle ear and respiratory system

198

1.11

0.14

1.5

1.2

28.32

35.73

mmol/l

0.90

177

Persons encountering health services in circumstances related to reproduction

173

1196

0.97

0.14

1.3

1.5

37.29

33.31

mmol/l

1.31

161

1075

Tonsillectomy and adenotomy

148

995

1.03

0.13

1.4

1.7

30.90

34.46

mmol/l

1.28

140

903

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

100

0.80

0.13

2.3

1.1

40.50

35.19

mmol/l

—

Abnormal findings on antenatal screening of mother

100

0.80

0.13

1.1

1.6

53.29

35.94

mmol/l

—

Calculus of kidney and ureter

927

0.96

0.12

1.5

1.2

35.02

34.76

mmol/l

0.03

812

Other and unspecified disorders of vitreous body

159

1509

1.03

0.12

1.3

1.1

36.38

33.29

mmol/l

1.00

137

1304

Hordeolum and other deep inflammation of eyelid

148

0.88

0.12

1.2

1.3

34.54

36.26

mmol/l

0.15

135

Other blood glucose lowering drugs, excl. Insulins

521

1.06

0.12

1.2

1.1

27.68

34.59

mmol/l

1.94

447

Varicella [chickenpox]

104

1.15

0.12

1.2

1.3

30.35

39.34

mmol/l

0.97

Multiple gestation

137

0.88

0.12

1.7

1.5

22.75

34.72

mmol/l

2.74

122

Dislocation, sprain and strain of joints and ligaments of knee

173

1605

0.97

0.11

1.3

1.2

33.90

34.23

mmol/l

0.07

159

1424

Complications predominantly related to the puerperium

537

0.95

0.11

1.2

1.3

29.83

33.36

mmol/l

0.65

472

Embedded teeth, including avohilmo

167

0.90

0.10

1.3

1.4

40.40

35.49

mmol/l

0.24

161

Pneumoconiosis due to asbestos and other mineral fibres

1.14

0.10

1.2

1.1

23.60

31.30

mmol/l

—

Loose body in joint

1.11

0.10

1.2

1.1

28.60

34.80

mmol/l

—

Benign mammary dysplasia

463

0.95

0.09

1.1

37.13

33.31

mmol/l

0.43

392

Disorders of breast

167

1436

1.02

0.09

1.2

32.27

32.57

mmol/l

0.06

138

1251

Benign neoplasm: Rectum

586

1.04

0.09

1.1

29.22

34.73

mmol/l

1.24

512

Cholecystectomy

257

2219

0.98

0.09

1.6

1.2

33.88

33.93

mmol/l

0.02

226

1918

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

1.11

0.09

2.2

42.00

35.58

mmol/l

—

Twin gestation

134

0.90

0.08

1.7

1.4

22.75

34.34

mmol/l

2.62

119

Varicella [chickenpox], including avohilmo

136

1.10

0.08

1.3

1.7

34.35

39.22

mmol/l

0.46

130

Primary open-angle glaucoma, strict

105

1019

1.03

0.08

1.1

32.26

35.02

mmol/l

0.75

855

113

0.88

0.08

2.4

1.3

34.10

35.05

mmol/l

—

105

Other/unspecified soft tissue disorders related to use, overuse and pressure

0.82

0.08

1.4

1.1

26.00

33.24

mmol/l

—

Placenta praevia

1.06

0.08

1.1

1.2

32.86

34.73

mmol/l

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

1.03

0.07

1.0

1.2

52.57

34.49

mmol/l

—

Benign neoplasm of urinary organs

133

0.90

0.07

1.5

1.1

33.14

36.40

mmol/l

0.19

120

Rubella [German measles]

0.82

0.07

1.0

1.3

22.00

38.08

mmol/l

—

Rubella [German measles], including avohilmo

0.82

0.07

1.0

1.3

22.00

38.08

mmol/l

—

Erythema nodosum

1.07

0.07

1.3

1.2

42.25

35.84

mmol/l

—

Other, unspecified and serous retinal detachments

0.86

0.07

1.1

33.56

37.66

mmol/l

—

Other disorders of patella

393

1.04

0.06

1.3

1.2

28.53

35.43

mmol/l

1.39

345

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

175

1336

1.02

0.06

1.3

1.2

35.30

33.41

mmol/l

0.49

157

1164

Medical abortion

213

1170

0.99

0.06

1.2

32.11

32.47

mmol/l

0.09

181

1018

Carcinoma in situ of other and unspecified sites

111

0.90

0.06

1.0

1.1

32.20

36.47

mmol/l

—

Diabetes mellitus in pregnancy

322

0.97

0.05

1.2

1.4

29.22

32.61

mmol/l

0.64

297

Maternal care for cervical incompetence

1.11

0.05

1.4

1.1

36.70

35.18

mmol/l

—

Benign neoplasm: Choroid

192

0.94

0.05

1.1

31.11

33.90

mmol/l

0.33

172

Other enthesopathies

841

1.02

0.05

1.2

37.19

33.74

mmol/l

0.74

744

Injury of muscle and tendon at shoulder and upper arm level

112

1100

1.02

0.05

1.0

1.1

35.03

36.02

mmol/l

0.19

102

961

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

116

1023

0.98

0.05

1.2

30.16

32.36

mmol/l

0.56

105

890

Endometriosis of pelvic peritoneum

315

1.04

0.05

1.3

1.1

34.35

32.70

mmol/l

0.16

273

Mixed conductive and sensorineural hearing loss

378

1.03

0.04

1.1

1.2

33.16

35.17

mmol/l

0.28

326

Nontoxic multinodular goitre

647

1.02

0.03

1.1

1.2

33.96

33.47

mmol/l

0.07

555

Benign neoplasm: Rectum, anus and anal canal

667

1.02

0.03

1.1

28.80

34.86

mmol/l

1.60

577

L02BG Aromatase inhibitors

115

1121

1.01

0.03

1.2

1.1

32.54

32.68

mmol/l

0.02

105

949

Normotensive glaucoma

300

1.03

0.03

1.1

35.10

34.59

mmol/l

0.04

254

Medicines for HER+ breast cancer

136

1254

1.01

0.02

1.2

32.54

32.72

mmol/l

0.03

125

1071

Nontoxic goitre/thyroid nodule

105

1038

1.01

0.02

1.1

1.2

32.21

33.47

mmol/l

0.31

885

Malignant melanoma of skin, including Hilmo

431

1.02

0.02

1.1

30.93

34.35

mmol/l

0.57

367

Glucagon-like peptide-1 (GLP-1) analogues

859

0.99

0.01

1.2

33.06

35.20

mmol/l

0.45

754

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

859

0.99

0.01

1.2

33.06

35.20

mmol/l

0.45

754

Other superficial mycoses, including avohilmo

243

1.03

0.01

1.7

1.2

34.05

37.07

mmol/l

0.30

225

Malignant melanoma of skin

367

0.98

0.01

1.1

30.26

33.37

mmol/l

0.45

314

Urolithiasis

101

1003

1.01

0.00

1.4

1.2

35.17

34.79

mmol/l

0.05

877

Endometriosis ASRM stages 1,2

376

0.98

0.00

1.3

1.2

33.59

31.82

mmol/l

0.18

329

Chronic diseases of tonsils and adenoids

257

1624

1.00

0.00

1.2

1.4

31.06

34.09

mmol/l

1.56

232

1446

Mandibular retrognathia

148

1.01

0.00

1.7

2.6

37.13

36.47

mmol/l

0.03

142

Oral lichen planus, including avohilmo , including avohilmo

195

0.97

0.00

1.3

1.1

34.50

34.06

mmol/l

0.03

173

LSIL lesion of the cervix uteri

191

0.99

0.00

1.4

1.2

33.26

35.20

mmol/l

0.14

172

Multiple delivery

184

0.98

0.00

1.1

1.3

29.31

34.11

mmol/l

0.31

161

Lichen ruber planus, wide definition including periferal and oral lichen planus

739

1.00

0.00

1.1

34.90

34.64

mmol/l

0.03

635

Motorcycle rider injured in other and unspecified transport accidents

103

0.97

0.00

1.6

1.2

30.90

37.61

mmol/l

—

Other puerperal infections

107

1.03

0.00

1.4

1.3

34.09

36.07

mmol/l

0.10

100

Acquired keratosis [keratoderma] palmaris et plantaris

0.00

0.0

1.0

—

30.62

—

Vitreous prolapse

0.00

0.0

1.2

—

52.46

—

Melanocytic naevi of ear and external auricular canal

0.00

0.0

1.0

—

37.88

—

Birth injury to scalp

0.00

0.0

3.0

—

33.14

—

Thoracic root disorders

0.00

0.0

1.0

—

27.40

—

Flatback syndrome

0.00

0.0

1.0

—

26.60

—

Café au lait spots

0.00

0.0

2.7

—

28.56

—

Pulmonary artery stenosis

0.00

-0.00

0.0

2.5

—

28.62

—

Osteogenesis imperfecta

0.00

-0.00

0.0

1.0

—

29.14

—

Microtia (small ears)

0.00

-0.00

0.0

3.4

—

26.40

—

Colour vision deficiencies

0.00

-0.00

0.0

1.8

—

42.48

—

Infections specific to the perinatal period

1.00

-0.00

4.8

2.3

51.33

35.87

mmol/l

—

Haemolytic disease of fetus and newborn

0.00

-0.00

0.0

2.7

—

35.00

—

Carcinoma in situ, bladder

100

1.00

-0.00

1.0

1.1

32.20

36.12

mmol/l

—

Malignant neoplasm of uterus, part unspecified

0.00

-0.00

0.0

1.0

—

36.00

—

Whooping cough

0.00

-0.00

0.0

1.8

—

43.00

—

Posteruptive colour changes of dental hard tissues

0.00

-0.00

0.0

1.0

—

43.86

—

Other infective spondylopathies

0.00

-0.00

0.0

1.0

—

32.33

—

Meningococcal infection, including avohilmo

0.00

-0.00

0.0

1.1

—

29.25

—

Cytomegaloviral hepatitis

0.00

-0.00

0.0

1.0

—

28.83

—

Sequelae of tuberculosis, including avohilmo

0.96

-0.00

1.2

1.1

39.60

33.51

mmol/l

—

Birth injury to peripheral nervous system

0.00

-0.00

0.0

1.8

—

52.00

—

Malignant neoplasm of meninges

0.00

-0.00

0.0

1.0

—

33.00

—

Meningococcal infection

0.00

-0.00

0.0

1.1

—

29.25

—

Erythrasma

0.00

-0.00

0.0

1.0

—

30.17

—

Liver disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

32.80

—

Lichen planopilaris

0.00

-0.00

0.0

1.0

—

28.60

—

Use of dimethyl fumarate

0.00

-0.00

0.0

1.1

—

38.25

—

Radiodermatitis

0.00

-0.00

0.0

1.0

—

33.80

—

Accessory breast

0.00

-0.00

0.0

1.1

—

43.25

—

Traumatic spondylopathy

0.00

-0.00

0.0

1.2

—

21.83

—

Respiratory distress of newborn

0.90

-0.00

4.1

2.9

47.33

34.93

mmol/l

—

Other and unspecified myoneural disorders

0.00

-0.00

0.0

1.0

—

45.33

—

Malignant neoplasm of penis

0.00

-0.00

0.0

1.0

—

27.33

—

Prepatellar bursitis

0.92

-0.00

1.2

36.33

36.53

mmol/l

—

Osteomyelitis of vertebra

0.00

-0.00

0.0

1.0

—

26.80

—

Tick-borne viral encephalitis, including avohilmo

0.00

-0.00

0.0

1.0

—

38.14

—

Osteochondrosis of ankle, juvenile

0.00

-0.00

0.0

1.0

—

43.86

—

Kaschin-Beck disease

0.00

-0.00

0.0

1.0

—

28.00

—

Injury of blood vessels at ankle and foot level

0.00

-0.00

0.0

1.0

—

33.40

—

Injury of blood vessels at shoulder and upper arm level

0.00

-0.00

0.0

1.0

—

30.00

—

Inhalation of gastric contents

0.00

-0.00

0.0

1.5

—

28.33

—

Tick-borne viral encephalitis

0.00

-0.00

0.0

1.0

—

38.14

—

Bradycardia, unspecified, drug-induced

0.00

-0.00

0.0

1.2

—

35.67

—

Carcinoma in situ of breast

0.00

-0.00

0.0

1.0

—

30.86

—

Benign neoplasm: Lymph nodes

0.00

-0.00

0.0

1.0

—

40.40

—

Benign neoplasm: Connective and other soft tissue of pelvis

0.00

-0.00

0.0

3.6

—

32.20

—

Choroidal detachment

0.00

-0.00

0.0

1.0

—

25.38

—

Disorders of glossopharyngeal nerve

0.00

-0.00

0.0

1.0

—

32.56

—

Congenital malformations of nose

0.00

-0.00

0.0

1.0

—

19.00

—

Miliary tuberculosis

0.00

-0.00

0.0

1.0

—

48.72

—

Retrobulbar neuritis in diseases classified elsewhere

0.00

-0.00

0.0

1.2

—

26.00

—

Benign neoplasm: Urinary organ, other/unspecified

0.00

-0.00

0.0

1.0

—

36.60

—

Maternal care for known or suspected disproportion

0.86

-0.00

1.2

1.4

18.80

34.11

mmol/l

—

Congenital malformations of nose, including avohilmo

0.00

-0.00

0.0

1.7

—

25.17

—

Craniosynostosis EXCLUDE syndromes

0.00

-0.00

0.0

1.8

—

31.25

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Potassium [Moles/volume] in Urine

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS